- Published on
Emergency and Acute Medicine – Juvenile Idiopathic Arthritis
Overview And Definition
Juvenile idiopathic arthritis (JIA), formerly termed juvenile rheumatoid arthritis, represents a group of chronic inflammatory arthritides beginning before 17 years of age and persisting for more than six weeks without an identifiable cause. It is the most common chronic rheumatologic disease of childhood, affecting up to 1 in 1,000 children, with a female predominance in most subtypes. JIA encompasses a heterogeneous spectrum of disease, and fewer than half of affected children achieve complete remission, with many experiencing relapsing or persistent disease into adulthood.
Pathophysiology And Disease Classification
JIA is believed to result from immune dysregulation triggered by environmental factors in genetically predisposed children. The condition is classified into several subtypes based on joint involvement, symmetry, systemic features, laboratory findings, and family history. These include systemic-onset, pauciarticular, polyarticular (RF-positive and RF-negative), psoriatic, enthesitis-related, and unclassified forms. Prognosis varies by subtype, with pauciarticular disease generally carrying the most favorable outcome.
Clinical Subtypes And Presentations
Systemic-onset JIA accounts for a minority of cases and affects boys and girls equally. It is characterized by high, quotidian fevers lasting longer than two weeks, often accompanied by arthritis that may appear weeks to months after fever onset. Additional features may include a transient salmon-colored rash, lymphadenopathy, hepatosplenomegaly, or serositis. These patients often appear acutely ill and are at significant risk for macrophage activation syndrome, a life-threatening hyperinflammatory condition with high mortality.
Pauciarticular JIA is the most common subtype and typically affects young girls between two and four years of age. It involves four or fewer joints within the first six months, most often the knees, and presents insidiously in otherwise well-appearing children. Uveitis occurs in a substantial proportion and may be asymptomatic, necessitating routine ophthalmologic screening. Some children progress to extended disease with a worse prognosis.
Polyarticular JIA involves five or more joints within six months and may resemble adult rheumatoid arthritis, particularly in older girls with positive rheumatoid factor. Joint involvement is often symmetric, affecting both small and large joints, and may include the cervical spine and temporomandibular joint. Systemic symptoms are generally mild, limited to fatigue or anemia.
Psoriatic JIA presents with asymmetric arthritis of large joints, frequently involving the lower extremities or spine, and may be associated with psoriasis, dactylitis, nail pitting, or a family history of psoriasis. Enthesitis-related arthritis primarily affects older boys and involves lower extremity joints and the sacroiliac region, often accompanied by limited spinal motion and uveitis.
History And Physical Examination
The hallmark presentation of JIA is gradual-onset joint stiffness and swelling that is worse in the morning or after periods of inactivity and improves with movement. Children with systemic-onset disease are more likely to present to the emergency department due to acute illness, whereas other subtypes evolve slowly. Rapid onset of severe pain, warmth, and erythema in a joint is atypical for JIA and should prompt evaluation for infection or other inflammatory causes. Physical examination should focus on identifying systemic illness, documenting joint involvement, assessing range of motion, and noting signs of inflammation or functional impairment.
Initial Evaluation And Diagnostic Strategy
The primary objectives in the acute setting are to exclude septic arthritis, malignancy, and other identifiable causes of joint inflammation, as well as complications related to long-term immunosuppressive therapy. Basic laboratory studies include complete blood count and inflammatory markers, with blood cultures added if the child appears ill. Additional testing such as ANA, RF, HLA-B27, and liver enzymes may aid in subtype classification. Imaging with plain radiographs may show early soft tissue swelling and effusion, with later findings including osteoporosis and joint destruction. Ultrasound is helpful for detecting small effusions and guiding arthrocentesis when infection is suspected.
Differential Diagnostic Considerations
The differential diagnosis is broad and includes trauma, septic arthritis, viral or bacterial infections, Lyme disease in endemic regions, rheumatic fever, connective tissue diseases, orthopedic disorders such as Legg–Calvé–Perthes disease, and malignancy. Severe pain out of proportion to exam findings or midshaft bone pain should raise concern for neoplasm.
Management In The Emergency Setting
Emergency care focuses on identifying serious alternative diagnoses and stabilizing ill-appearing children. Toxic-appearing patients require prompt supportive care, including oxygen and intravenous access. For known JIA patients presenting with disease flares, management should be coordinated with the child’s rheumatologist. Antibiotics are reserved for confirmed or strongly suspected joint infection.
Pharmacologic Therapy Principles
Treatment strategies aim to control inflammation, preserve joint function, and support normal growth. Mild forms of JIA may respond to nonsteroidal anti-inflammatory drugs alone, while more severe or systemic disease often necessitates disease-modifying antirheumatic drugs or biologic agents. Early aggressive therapy is now common to reduce long-term complications. NSAIDs remain first-line for many patients, while intra-articular corticosteroid injections can provide prolonged relief in selected joints. Systemic corticosteroids, methotrexate, sulfasalazine, and biologic agents targeting specific cytokines are used based on disease severity and subtype, with careful monitoring for immunosuppression and adverse effects.
Disposition And Long-Term Care
Hospital admission is indicated when diagnosis is uncertain, the child appears systemically ill, or septic arthritis is suspected. Most stable patients without infection may be discharged once pain is controlled and follow-up is assured. Long-term management requires regular rheumatology care, and children—particularly those with pauciarticular disease—must undergo frequent ophthalmologic examinations to detect silent uveitis before irreversible damage occurs.
Key Clinical Insights And Common Pitfalls
Always exclude acute joint infection, particularly in endemic areas for Lyme disease. Prolonged daily fevers with arthritis unresponsive to antibiotics should prompt consideration of systemic-onset JIA. Be vigilant for macrophage activation syndrome in children with systemic disease who appear septic or deteriorate rapidly. A careful review of current medications is essential to identify adverse effects or immunosuppression that may alter presentation and risk.
Overview And Definition
Juvenile idiopathic arthritis (JIA), formerly termed juvenile rheumatoid arthritis, represents a group of chronic inflammatory arthritides beginning before 17 years of age and persisting for more than six weeks without an identifiable cause. It is the most common chronic rheumatologic disease of childhood, affecting up to 1 in 1,000 children, with a female predominance in most subtypes. JIA encompasses a heterogeneous spectrum of disease, and fewer than half of affected children achieve complete remission, with many experiencing relapsing or persistent disease into adulthood.
Pathophysiology And Disease Classification
JIA is believed to result from immune dysregulation triggered by environmental factors in genetically predisposed children. The condition is classified into several subtypes based on joint involvement, symmetry, systemic features, laboratory findings, and family history. These include systemic-onset, pauciarticular, polyarticular (RF-positive and RF-negative), psoriatic, enthesitis-related, and unclassified forms. Prognosis varies by subtype, with pauciarticular disease generally carrying the most favorable outcome.
Clinical Subtypes And Presentations
Systemic-onset JIA accounts for a minority of cases and affects boys and girls equally. It is characterized by high, quotidian fevers lasting longer than two weeks, often accompanied by arthritis that may appear weeks to months after fever onset. Additional features may include a transient salmon-colored rash, lymphadenopathy, hepatosplenomegaly, or serositis. These patients often appear acutely ill and are at significant risk for macrophage activation syndrome, a life-threatening hyperinflammatory condition with high mortality.
Pauciarticular JIA is the most common subtype and typically affects young girls between two and four years of age. It involves four or fewer joints within the first six months, most often the knees, and presents insidiously in otherwise well-appearing children. Uveitis occurs in a substantial proportion and may be asymptomatic, necessitating routine ophthalmologic screening. Some children progress to extended disease with a worse prognosis.
Polyarticular JIA involves five or more joints within six months and may resemble adult rheumatoid arthritis, particularly in older girls with positive rheumatoid factor. Joint involvement is often symmetric, affecting both small and large joints, and may include the cervical spine and temporomandibular joint. Systemic symptoms are generally mild, limited to fatigue or anemia.
Psoriatic JIA presents with asymmetric arthritis of large joints, frequently involving the lower extremities or spine, and may be associated with psoriasis, dactylitis, nail pitting, or a family history of psoriasis. Enthesitis-related arthritis primarily affects older boys and involves lower extremity joints and the sacroiliac region, often accompanied by limited spinal motion and uveitis.
History And Physical Examination
The hallmark presentation of JIA is gradual-onset joint stiffness and swelling that is worse in the morning or after periods of inactivity and improves with movement. Children with systemic-onset disease are more likely to present to the emergency department due to acute illness, whereas other subtypes evolve slowly. Rapid onset of severe pain, warmth, and erythema in a joint is atypical for JIA and should prompt evaluation for infection or other inflammatory causes. Physical examination should focus on identifying systemic illness, documenting joint involvement, assessing range of motion, and noting signs of inflammation or functional impairment.
Initial Evaluation And Diagnostic Strategy
The primary objectives in the acute setting are to exclude septic arthritis, malignancy, and other identifiable causes of joint inflammation, as well as complications related to long-term immunosuppressive therapy. Basic laboratory studies include complete blood count and inflammatory markers, with blood cultures added if the child appears ill. Additional testing such as ANA, RF, HLA-B27, and liver enzymes may aid in subtype classification. Imaging with plain radiographs may show early soft tissue swelling and effusion, with later findings including osteoporosis and joint destruction. Ultrasound is helpful for detecting small effusions and guiding arthrocentesis when infection is suspected.
Differential Diagnostic Considerations
The differential diagnosis is broad and includes trauma, septic arthritis, viral or bacterial infections, Lyme disease in endemic regions, rheumatic fever, connective tissue diseases, orthopedic disorders such as Legg–Calvé–Perthes disease, and malignancy. Severe pain out of proportion to exam findings or midshaft bone pain should raise concern for neoplasm.
Management In The Emergency Setting
Emergency care focuses on identifying serious alternative diagnoses and stabilizing ill-appearing children. Toxic-appearing patients require prompt supportive care, including oxygen and intravenous access. For known JIA patients presenting with disease flares, management should be coordinated with the child’s rheumatologist. Antibiotics are reserved for confirmed or strongly suspected joint infection.
Pharmacologic Therapy Principles
Treatment strategies aim to control inflammation, preserve joint function, and support normal growth. Mild forms of JIA may respond to nonsteroidal anti-inflammatory drugs alone, while more severe or systemic disease often necessitates disease-modifying antirheumatic drugs or biologic agents. Early aggressive therapy is now common to reduce long-term complications. NSAIDs remain first-line for many patients, while intra-articular corticosteroid injections can provide prolonged relief in selected joints. Systemic corticosteroids, methotrexate, sulfasalazine, and biologic agents targeting specific cytokines are used based on disease severity and subtype, with careful monitoring for immunosuppression and adverse effects.
Disposition And Long-Term Care
Hospital admission is indicated when diagnosis is uncertain, the child appears systemically ill, or septic arthritis is suspected. Most stable patients without infection may be discharged once pain is controlled and follow-up is assured. Long-term management requires regular rheumatology care, and children—particularly those with pauciarticular disease—must undergo frequent ophthalmologic examinations to detect silent uveitis before irreversible damage occurs.
Key Clinical Insights And Common Pitfalls
Always exclude acute joint infection, particularly in endemic areas for Lyme disease. Prolonged daily fevers with arthritis unresponsive to antibiotics should prompt consideration of systemic-onset JIA. Be vigilant for macrophage activation syndrome in children with systemic disease who appear septic or deteriorate rapidly. A careful review of current medications is essential to identify adverse effects or immunosuppression that may alter presentation and risk.
- Published on
Emergency and Acute Medicine – Pediatric Asthma
Clinical Overview
Pediatric asthma is a common inflammatory airway disease affecting about 2.7 million children (<18 years) in the united states and accounts for roughly 850,000 emergency department visits annually. viral-driven airway inflammation commonly triggers bronchoconstriction, which is amplified by hyperreactivity inflammatory mediators. resulting airflow obstruction increases resistance causes gas trapping, driven mucosal edema, bronchospasm, mucus plugging. infants are particularly prone to respiratory failure because of higher peripheral resistance, reduced elastic recoil with earlier closure, an unstable rib cage, a mechanically disadvantaged diaphragm. risk influenced family history allergy early injury or vulnerability such as bronchopulmonary dysplasia, prior pneumonia, intubation, croup, reflux, passive smoke exposure; reactions foods medications other allergic conditions also support atopic predisposition. environmental exposures including pets, cigarette smoke, carpets, dust can precipitate worsen symptoms.< />pan>
Common Causes And Triggers
Exacerbations are often precipitated by infection, most commonly viral but sometimes bacterial. Environmental allergens and irritants are frequent contributors, including pollens, grasses, mold, house dust mites, and animal dander, as well as airborne chemicals such as chlorine or ammonia and food-related additives. Smoke, pollutants, gases, and aerosols may aggravate bronchospasm. Exercise, cold weather, and emotional stressors (including phobias) can provoke symptoms. Medication-related triggers include beta-blockers, aspirin, and NSAIDs.
Clinical Features
Children may present with fatigue or somnolence, diaphoresis, agitation, hypoxia or cyanosis, tachycardia, dehydration, and pulsus paradoxus. Respiratory findings include wheezing, rales, or rhonchi; acute or chronic cough; tachypnea; chest tightness; dyspnea with a prolonged expiratory phase; retractions with accessory muscle use and nasal flaring; and signs of hyperinflation. Many have a history of recurrent episodes and chronic activity restriction. Potential complications include recurrent pneumonia or bronchitis, atelectasis, pneumothorax or pneumomediastinum, and in severe cases respiratory distress, respiratory failure, or death.
History And Examination
History should focus on precipitating events and known triggers, symptom duration and progression, comorbid illness, and prior disease severity markers including previous hospitalizations, prior intubations or ICU care, and current regular or intermittent medications. Examination should include vital signs with pulse oximetry and a focused respiratory assessment. Wheeze intensity can be misleading; absent wheezing may indicate critically reduced airflow with diminished breath sounds. Look for hypoxia through skin and nail bed color changes and assess for fatigue or impending failure by noting accessory muscle use or retractions, lethargy, confusion, somnolence, or exhaustion.
Essential Evaluation
Diagnosis is clinical and relies on history and physical examination. Ventilation is assessed by observing work of breathing (retractions and accessory muscle use) and by auscultation for air exchange. Clinical response to bronchodilators should be tracked in the current episode and interpreted in the context of prior episodes. Alternative diagnoses must be considered and excluded. Initial pulse oximetry is important; an oxygen saturation below 91% at sea level correlates with more significant illness and is associated with admission risk, relapse, and a more prolonged course. Peak flow measurement can help in cooperative children, typically those older than five years; values below 50–70% of predicted suggest moderate to severe obstruction, 70–90% aligns with mild to moderate disease, and above 90% is considered normal.
Tests And Imaging
Arterial blood gas testing is not routine and is not mandatory; it can supplement oximetry for oxygenation assessment and support clinical judgment about ventilation when needed. CBC may be obtained as a nonspecific marker when infection is a concern. Theophylline levels are relevant only if a child is taking theophylline, though this therapy is not recommended. Chest radiography is considered selectively to evaluate for infiltrates, bronchial wall thickening, or hyperexpansion, and is especially considered in infants under one year to help exclude foreign body aspiration or atelectasis, in a first episode of significant wheezing to help assess chronicity and alternative diagnoses, in worsening distress or poor response to therapy, in respiratory distress or failure, and in shortness of breath without wheeze.
Differential Diagnosis
Infectious or inflammatory mimics include bronchiolitis, which can be difficult to distinguish clinically aside from age and history, and pneumonia of viral, bacterial, chemical, or hypersensitivity origin. Aspiration, deep neck or mediastinal abscesses or masses, and anaphylaxis must be considered. Structural and anatomic problems include pneumothorax and foreign body aspiration. Vascular causes include tracheal compression from vascular anomalies, pulmonary embolism, and heart failure. Congenital and chronic disorders include cystic fibrosis, tracheoesophageal fistula, bronchogenic cysts, and congenital heart disease. Other considerations include intoxication or medication effects, metabolic acidosis, neoplasm, vocal cord dysfunction, pulmonary edema (cardiogenic or noncardiogenic), and gastroesophageal reflux.
Prehospital Care
Field care emphasizes oxygen and continuous oxygen saturation monitoring, nebulized beta-agonist therapy such as albuterol, and rapid transport with clear communication to the receiving emergency team. Intubation is required for respiratory failure or profound fatigue. Intravenous fluids should be given when dehydration is evident.
Initial Stabilization In The ED
The immediate goal is to maintain oxygen saturation above 90–95% while initiating inhaled beta-agonist therapy. Intubation is indicated for respiratory failure. If dehydration is present, administer a 20 mL/kg bolus of 0.9% normal saline.
Emergency Department Management
Evaluate for impending respiratory failure, focusing on cyanosis, severe anxiety or irritability, lethargy or somnolence, fatigue, persistent tachypnea, markedly reduced air entry, and poor ventilation. Oxygen should be titrated to maintain saturations above 95% at sea level. Albuterol is the primary bronchodilator and may be given frequently or continuously in severe exacerbations. Levalbuterol may be associated with fewer side effects and may allow less frequent dosing in some children. Ipratropium bromide can be added as an adjunct, with the best benefit seen when combined with the first three beta-agonist treatments in moderate to severe presentations. Systemic steroids are recommended, using oral administration for moderate exacerbations when oral intake is possible and intravenous dosing for severe illness or inability to tolerate oral medications; a single dose of dexamethasone may be comparable to more traditional steroid courses. Subcutaneous epinephrine or terbutaline is reserved for severe or refractory cases and is used infrequently. Magnesium sulfate may help in severe asthma that persists despite standard therapy. If intubation is required, ketamine is a useful induction agent. A 20 mL/kg normal saline bolus remains appropriate if dehydration is present. Heliox may be considered, although evidence is mixed and results remain inconclusive.
Medication Regimens
Albuterol may be given by nebulizer at 0.15 mg/kg per dose up to 5 mg per dose every 15–30 minutes as needed, or via MDI with spacer at 90 micrograms per puff using two puffs every 5–10 minutes to a maximum of 10 puffs. Dexamethasone can be given at 0.3 mg/kg per dose up to 16 mg. Epinephrine 1:1,000 may be administered subcutaneously at 0.01 mg/kg up to 0.35 mL per dose every 20 minutes for up to three doses. Ipratropium bromide nebulizer dosing is 250–500 micrograms per dose every six hours. Ketamine for intubation is typically 1–2 mg/kg IV as an induction agent. Levalbuterol is available in 0.63 mg and 1.25 mg vials for nebulization, typically dosed every 6–8 hours. Magnesium sulfate is dosed at 25 mg/kg IV over 20 minutes, with a maximum of about 1.2–2 g per dose. Methylprednisolone is given at 1–2 mg/kg per dose IV every six hours with a maximum of 125 mg per dose. Prednisolone is dosed 1–2 mg/kg per dose orally every 12 hours, and prednisone 1–2 mg/kg per dose orally every 6–12 hours with a maximum of 80 mg per dose. Terbutaline may be given subcutaneously as 0.01 mL/kg of 0.01% solution every 15–20 minutes up to 0.25 mL per dose, with repeated dosing per protocol. First-line therapy is albuterol plus systemic steroids with ipratropium as an adjunct, while second-line escalation includes epinephrine or terbutaline and magnesium sulfate.
Disposition And Observation
Admission decisions should be individualized using symptoms, examination, and objective measurements. Hospital admission is generally indicated for persistent wheezing, ongoing tachypnea, continued retractions or accessory muscle use, room-air saturation below 93% at sea level, peak flow below 50–70% predicted, inability to tolerate oral fluids or medications, a return ED visit within the prior 24 hours, and significant comorbidities such as congenital heart disease, bronchopulmonary dysplasia, cystic fibrosis, or neuromuscular disease, as well as concomitant pneumonia or severe viral infection. ICU-level care is indicated for severe respiratory distress, saturation below 90% or PaO2 below 60 mm Hg while receiving 40% oxygen, PaCO2 above 40 mm Hg, or significant complications such as pneumothorax or dysrhythmia. Discharge is appropriate only after a clearly good response to treatment and after observing the child for 60 minutes after the last therapy. Discharge targets include peak flow above 70% predicted for age and height, room-air saturation above 93% at sea level, normal respiratory rate, no retractions, clear lungs or only minimal wheeze, minimal or no dyspnea, and reliable follow-up and adherence. Discharge planning should include reducing exposure to smoke and allergens, continuing an intensive beta-agonist regimen for 3–5 days, and prescribing a short 3–5 day steroid course at 2 mg/kg/day for those with at least moderate symptoms. Children with moderate or severe exacerbations should have arrangements for inhaled corticosteroids over the next 1–2 months, such as fluticasone, budesonide, or beclomethasone. Follow-up should be arranged within 24–72 hours, with clear return precautions for shortness of breath that does not respond to the home regimen. Longer-term controller planning should be considered for children with recurrent attacks, persistent symptoms, or activity limitation.
Follow-Up Planning
Ongoing care is typically coordinated through the primary care clinician and often includes inhaled steroid maintenance therapy, instruction in rescue treatment, and education to support early recognition and appropriate escalation during future exacerbations.
Clinical Lessons And Safety Points
Rapid initiation of therapy with frequent reassessment is crucial to detect deterioration early. When admitting children, ensure that beta-agonist treatments continue without interruption.
Clinical Overview
Pediatric asthma is a common inflammatory airway disease affecting about 2.7 million children (<18 years) in the united states and accounts for roughly 850,000 emergency department visits annually. viral-driven airway inflammation commonly triggers bronchoconstriction, which is amplified by hyperreactivity inflammatory mediators. resulting airflow obstruction increases resistance causes gas trapping, driven mucosal edema, bronchospasm, mucus plugging. infants are particularly prone to respiratory failure because of higher peripheral resistance, reduced elastic recoil with earlier closure, an unstable rib cage, a mechanically disadvantaged diaphragm. risk influenced family history allergy early injury or vulnerability such as bronchopulmonary dysplasia, prior pneumonia, intubation, croup, reflux, passive smoke exposure; reactions foods medications other allergic conditions also support atopic predisposition. environmental exposures including pets, cigarette smoke, carpets, dust can precipitate worsen symptoms.< />pan>
Common Causes And Triggers
Exacerbations are often precipitated by infection, most commonly viral but sometimes bacterial. Environmental allergens and irritants are frequent contributors, including pollens, grasses, mold, house dust mites, and animal dander, as well as airborne chemicals such as chlorine or ammonia and food-related additives. Smoke, pollutants, gases, and aerosols may aggravate bronchospasm. Exercise, cold weather, and emotional stressors (including phobias) can provoke symptoms. Medication-related triggers include beta-blockers, aspirin, and NSAIDs.
Clinical Features
Children may present with fatigue or somnolence, diaphoresis, agitation, hypoxia or cyanosis, tachycardia, dehydration, and pulsus paradoxus. Respiratory findings include wheezing, rales, or rhonchi; acute or chronic cough; tachypnea; chest tightness; dyspnea with a prolonged expiratory phase; retractions with accessory muscle use and nasal flaring; and signs of hyperinflation. Many have a history of recurrent episodes and chronic activity restriction. Potential complications include recurrent pneumonia or bronchitis, atelectasis, pneumothorax or pneumomediastinum, and in severe cases respiratory distress, respiratory failure, or death.
History And Examination
History should focus on precipitating events and known triggers, symptom duration and progression, comorbid illness, and prior disease severity markers including previous hospitalizations, prior intubations or ICU care, and current regular or intermittent medications. Examination should include vital signs with pulse oximetry and a focused respiratory assessment. Wheeze intensity can be misleading; absent wheezing may indicate critically reduced airflow with diminished breath sounds. Look for hypoxia through skin and nail bed color changes and assess for fatigue or impending failure by noting accessory muscle use or retractions, lethargy, confusion, somnolence, or exhaustion.
Essential Evaluation
Diagnosis is clinical and relies on history and physical examination. Ventilation is assessed by observing work of breathing (retractions and accessory muscle use) and by auscultation for air exchange. Clinical response to bronchodilators should be tracked in the current episode and interpreted in the context of prior episodes. Alternative diagnoses must be considered and excluded. Initial pulse oximetry is important; an oxygen saturation below 91% at sea level correlates with more significant illness and is associated with admission risk, relapse, and a more prolonged course. Peak flow measurement can help in cooperative children, typically those older than five years; values below 50–70% of predicted suggest moderate to severe obstruction, 70–90% aligns with mild to moderate disease, and above 90% is considered normal.
Tests And Imaging
Arterial blood gas testing is not routine and is not mandatory; it can supplement oximetry for oxygenation assessment and support clinical judgment about ventilation when needed. CBC may be obtained as a nonspecific marker when infection is a concern. Theophylline levels are relevant only if a child is taking theophylline, though this therapy is not recommended. Chest radiography is considered selectively to evaluate for infiltrates, bronchial wall thickening, or hyperexpansion, and is especially considered in infants under one year to help exclude foreign body aspiration or atelectasis, in a first episode of significant wheezing to help assess chronicity and alternative diagnoses, in worsening distress or poor response to therapy, in respiratory distress or failure, and in shortness of breath without wheeze.
Differential Diagnosis
Infectious or inflammatory mimics include bronchiolitis, which can be difficult to distinguish clinically aside from age and history, and pneumonia of viral, bacterial, chemical, or hypersensitivity origin. Aspiration, deep neck or mediastinal abscesses or masses, and anaphylaxis must be considered. Structural and anatomic problems include pneumothorax and foreign body aspiration. Vascular causes include tracheal compression from vascular anomalies, pulmonary embolism, and heart failure. Congenital and chronic disorders include cystic fibrosis, tracheoesophageal fistula, bronchogenic cysts, and congenital heart disease. Other considerations include intoxication or medication effects, metabolic acidosis, neoplasm, vocal cord dysfunction, pulmonary edema (cardiogenic or noncardiogenic), and gastroesophageal reflux.
Prehospital Care
Field care emphasizes oxygen and continuous oxygen saturation monitoring, nebulized beta-agonist therapy such as albuterol, and rapid transport with clear communication to the receiving emergency team. Intubation is required for respiratory failure or profound fatigue. Intravenous fluids should be given when dehydration is evident.
Initial Stabilization In The ED
The immediate goal is to maintain oxygen saturation above 90–95% while initiating inhaled beta-agonist therapy. Intubation is indicated for respiratory failure. If dehydration is present, administer a 20 mL/kg bolus of 0.9% normal saline.
Emergency Department Management
Evaluate for impending respiratory failure, focusing on cyanosis, severe anxiety or irritability, lethargy or somnolence, fatigue, persistent tachypnea, markedly reduced air entry, and poor ventilation. Oxygen should be titrated to maintain saturations above 95% at sea level. Albuterol is the primary bronchodilator and may be given frequently or continuously in severe exacerbations. Levalbuterol may be associated with fewer side effects and may allow less frequent dosing in some children. Ipratropium bromide can be added as an adjunct, with the best benefit seen when combined with the first three beta-agonist treatments in moderate to severe presentations. Systemic steroids are recommended, using oral administration for moderate exacerbations when oral intake is possible and intravenous dosing for severe illness or inability to tolerate oral medications; a single dose of dexamethasone may be comparable to more traditional steroid courses. Subcutaneous epinephrine or terbutaline is reserved for severe or refractory cases and is used infrequently. Magnesium sulfate may help in severe asthma that persists despite standard therapy. If intubation is required, ketamine is a useful induction agent. A 20 mL/kg normal saline bolus remains appropriate if dehydration is present. Heliox may be considered, although evidence is mixed and results remain inconclusive.
Medication Regimens
Albuterol may be given by nebulizer at 0.15 mg/kg per dose up to 5 mg per dose every 15–30 minutes as needed, or via MDI with spacer at 90 micrograms per puff using two puffs every 5–10 minutes to a maximum of 10 puffs. Dexamethasone can be given at 0.3 mg/kg per dose up to 16 mg. Epinephrine 1:1,000 may be administered subcutaneously at 0.01 mg/kg up to 0.35 mL per dose every 20 minutes for up to three doses. Ipratropium bromide nebulizer dosing is 250–500 micrograms per dose every six hours. Ketamine for intubation is typically 1–2 mg/kg IV as an induction agent. Levalbuterol is available in 0.63 mg and 1.25 mg vials for nebulization, typically dosed every 6–8 hours. Magnesium sulfate is dosed at 25 mg/kg IV over 20 minutes, with a maximum of about 1.2–2 g per dose. Methylprednisolone is given at 1–2 mg/kg per dose IV every six hours with a maximum of 125 mg per dose. Prednisolone is dosed 1–2 mg/kg per dose orally every 12 hours, and prednisone 1–2 mg/kg per dose orally every 6–12 hours with a maximum of 80 mg per dose. Terbutaline may be given subcutaneously as 0.01 mL/kg of 0.01% solution every 15–20 minutes up to 0.25 mL per dose, with repeated dosing per protocol. First-line therapy is albuterol plus systemic steroids with ipratropium as an adjunct, while second-line escalation includes epinephrine or terbutaline and magnesium sulfate.
Disposition And Observation
Admission decisions should be individualized using symptoms, examination, and objective measurements. Hospital admission is generally indicated for persistent wheezing, ongoing tachypnea, continued retractions or accessory muscle use, room-air saturation below 93% at sea level, peak flow below 50–70% predicted, inability to tolerate oral fluids or medications, a return ED visit within the prior 24 hours, and significant comorbidities such as congenital heart disease, bronchopulmonary dysplasia, cystic fibrosis, or neuromuscular disease, as well as concomitant pneumonia or severe viral infection. ICU-level care is indicated for severe respiratory distress, saturation below 90% or PaO2 below 60 mm Hg while receiving 40% oxygen, PaCO2 above 40 mm Hg, or significant complications such as pneumothorax or dysrhythmia. Discharge is appropriate only after a clearly good response to treatment and after observing the child for 60 minutes after the last therapy. Discharge targets include peak flow above 70% predicted for age and height, room-air saturation above 93% at sea level, normal respiratory rate, no retractions, clear lungs or only minimal wheeze, minimal or no dyspnea, and reliable follow-up and adherence. Discharge planning should include reducing exposure to smoke and allergens, continuing an intensive beta-agonist regimen for 3–5 days, and prescribing a short 3–5 day steroid course at 2 mg/kg/day for those with at least moderate symptoms. Children with moderate or severe exacerbations should have arrangements for inhaled corticosteroids over the next 1–2 months, such as fluticasone, budesonide, or beclomethasone. Follow-up should be arranged within 24–72 hours, with clear return precautions for shortness of breath that does not respond to the home regimen. Longer-term controller planning should be considered for children with recurrent attacks, persistent symptoms, or activity limitation.
Follow-Up Planning
Ongoing care is typically coordinated through the primary care clinician and often includes inhaled steroid maintenance therapy, instruction in rescue treatment, and education to support early recognition and appropriate escalation during future exacerbations.
Clinical Lessons And Safety Points
Rapid initiation of therapy with frequent reassessment is crucial to detect deterioration early. When admitting children, ensure that beta-agonist treatments continue without interruption.
- Published on
Emergency and Acute Medicine – Monoarticular Arthritis
Clinical Overview
Monoarticular arthritis refers to inflammation confined to a single joint and is never migratory. The presence of one cause does not exclude another, and rapid identification of the underlying etiology is critical because outcomes range from benign self-limited disease to rapidly destructive infection with permanent disability. Causes broadly include infectious, crystalline, inflammatory, and noninflammatory processes, each with distinct urgency and management priorities.
Pathophysiology And Etiologic Categories
Septic arthritis represents the most time-sensitive cause, as bacterial invasion of the joint leads to rapid cartilage destruction. Infection may arise from hematogenous spread, contiguous extension from nearby soft tissue or bone, or direct inoculation through trauma or procedures. Risk is increased in patients with immunosuppression, intravenous drug use, preexisting joint disease, or prosthetic joints. Crystalline arthritis includes gout, caused by monosodium urate deposition from overproduction or underexcretion of uric acid, and pseudogout, caused by calcium pyrophosphate deposition. Inflammatory causes include rheumatoid arthritis, psoriatic arthritis, and reactive arthritis, where monoarticular involvement may be an early manifestation. Noninflammatory etiologies encompass osteoarthritis, trauma, hemarthrosis, neuropathic joints, and mechanical overload.
Pediatric-Specific Considerations
In children, septic arthritis is uncommon but carries high morbidity and requires immediate intervention. The hip and knee are most frequently affected, often with coexisting osteomyelitis. Any child presenting with an acutely swollen, painful joint and systemic symptoms mandates urgent aspiration, empiric antibiotics, and hospital admission. Noninfectious causes in children include epiphyseal plate injuries, congenital hip disorders, slipped capital femoral epiphysis in overweight adolescents, Legg–Calvé–Perthes disease, and bleeding disorders.
Clinical Presentation And History
Patients typically present with acute joint pain, swelling, warmth, erythema, and reduced range of motion, often refusing to bear weight. Septic arthritis commonly presents with fever and systemic illness, with large joints such as the knee and hip most often involved. Gonococcal arthritis may be associated with urethral symptoms, while Lyme arthritis often presents with knee swelling and a history of tick exposure. Gout manifests as sudden, severe pain with recurrent self-limited flares, classically affecting the first metatarsophalangeal joint, whereas pseudogout more often involves the knee or wrist. Degenerative disease presents with stiffness after inactivity and pain with use, while neuropathic joints may show profound destruction with surprisingly little pain. A thorough history should address prior joint disease, systemic illnesses, immune status, medication use, substance use, sexual history, and trauma.
Physical Examination
Examination focuses on confirming true intra-articular pathology, assessing neurovascular status, identifying signs of systemic illness, and evaluating for features suggestive of chronic disease such as muscle atrophy or skin changes. Pain with both active and passive motion strongly suggests intra-articular involvement.
Diagnostic Strategy
Accurate and timely diagnosis reduces morbidity and preserves function. Arthrocentesis with synovial fluid analysis is the cornerstone of evaluation and should be performed promptly unless contraindicated. Blood tests alone are insufficient for diagnosis and serve only as supportive data.
Laboratory And Imaging Evaluation
Synovial fluid analysis provides definitive diagnostic information. High white blood cell counts with neutrophil predominance increase suspicion for infection, particularly when exceeding 50,000 cells/mm³. Synovial glucose significantly lower than serum levels supports septic arthritis. Gram stain guides early antibiotic selection, while culture confirms the organism. Crystal analysis under polarized light identifies gout or pseudogout. Imaging with plain radiographs assesses fractures, chronic joint changes, and effusions, while ultrasound assists in detecting fluid collections and guiding aspiration. MRI is reserved for suspected occult fracture, osteonecrosis, or deep infection.
Management Principles
Initial care includes joint immobilization in a position of comfort, vascular access, analgesia, and early aspiration. Septic arthritis requires immediate empiric intravenous antibiotics and urgent orthopedic consultation, often followed by surgical irrigation. Crystalline arthritis management focuses first on controlling the acute flare with NSAIDs, colchicine, or corticosteroids, followed later by prophylactic and urate-lowering therapy once the flare resolves. Noninflammatory causes are managed with analgesia, anti-inflammatory agents, physical therapy, and orthopedic intervention when indicated. Hemorrhagic arthritis requires correction of underlying coagulopathy.
Disposition And Follow-Up
Admission is required for all cases of septic arthritis, patients unable to perform activities of daily living, those with systemic illness, metabolic derangements, intractable pain, or joints requiring surgical intervention. Discharge may be appropriate when symptoms are controlled, comorbidities are stable, medications are accessible, and reliable follow-up is ensured. Prompt referral to appropriate specialists is essential for definitive management.
Key Clinical Insights And Diagnostic Traps
Synovial fluid aspiration with Gram stain and analysis is the single most important diagnostic step and should not be delayed. Septic arthritis must be assumed until definitively excluded, particularly in patients with diabetes, immunosuppression, recent joint injections, trauma, or overlying cellulitis. Intra-articular corticosteroids should never be administered until infection has been ruled out, as this may worsen outcomes and obscure diagnosis.
Clinical Overview
Monoarticular arthritis refers to inflammation confined to a single joint and is never migratory. The presence of one cause does not exclude another, and rapid identification of the underlying etiology is critical because outcomes range from benign self-limited disease to rapidly destructive infection with permanent disability. Causes broadly include infectious, crystalline, inflammatory, and noninflammatory processes, each with distinct urgency and management priorities.
Pathophysiology And Etiologic Categories
Septic arthritis represents the most time-sensitive cause, as bacterial invasion of the joint leads to rapid cartilage destruction. Infection may arise from hematogenous spread, contiguous extension from nearby soft tissue or bone, or direct inoculation through trauma or procedures. Risk is increased in patients with immunosuppression, intravenous drug use, preexisting joint disease, or prosthetic joints. Crystalline arthritis includes gout, caused by monosodium urate deposition from overproduction or underexcretion of uric acid, and pseudogout, caused by calcium pyrophosphate deposition. Inflammatory causes include rheumatoid arthritis, psoriatic arthritis, and reactive arthritis, where monoarticular involvement may be an early manifestation. Noninflammatory etiologies encompass osteoarthritis, trauma, hemarthrosis, neuropathic joints, and mechanical overload.
Pediatric-Specific Considerations
In children, septic arthritis is uncommon but carries high morbidity and requires immediate intervention. The hip and knee are most frequently affected, often with coexisting osteomyelitis. Any child presenting with an acutely swollen, painful joint and systemic symptoms mandates urgent aspiration, empiric antibiotics, and hospital admission. Noninfectious causes in children include epiphyseal plate injuries, congenital hip disorders, slipped capital femoral epiphysis in overweight adolescents, Legg–Calvé–Perthes disease, and bleeding disorders.
Clinical Presentation And History
Patients typically present with acute joint pain, swelling, warmth, erythema, and reduced range of motion, often refusing to bear weight. Septic arthritis commonly presents with fever and systemic illness, with large joints such as the knee and hip most often involved. Gonococcal arthritis may be associated with urethral symptoms, while Lyme arthritis often presents with knee swelling and a history of tick exposure. Gout manifests as sudden, severe pain with recurrent self-limited flares, classically affecting the first metatarsophalangeal joint, whereas pseudogout more often involves the knee or wrist. Degenerative disease presents with stiffness after inactivity and pain with use, while neuropathic joints may show profound destruction with surprisingly little pain. A thorough history should address prior joint disease, systemic illnesses, immune status, medication use, substance use, sexual history, and trauma.
Physical Examination
Examination focuses on confirming true intra-articular pathology, assessing neurovascular status, identifying signs of systemic illness, and evaluating for features suggestive of chronic disease such as muscle atrophy or skin changes. Pain with both active and passive motion strongly suggests intra-articular involvement.
Diagnostic Strategy
Accurate and timely diagnosis reduces morbidity and preserves function. Arthrocentesis with synovial fluid analysis is the cornerstone of evaluation and should be performed promptly unless contraindicated. Blood tests alone are insufficient for diagnosis and serve only as supportive data.
Laboratory And Imaging Evaluation
Synovial fluid analysis provides definitive diagnostic information. High white blood cell counts with neutrophil predominance increase suspicion for infection, particularly when exceeding 50,000 cells/mm³. Synovial glucose significantly lower than serum levels supports septic arthritis. Gram stain guides early antibiotic selection, while culture confirms the organism. Crystal analysis under polarized light identifies gout or pseudogout. Imaging with plain radiographs assesses fractures, chronic joint changes, and effusions, while ultrasound assists in detecting fluid collections and guiding aspiration. MRI is reserved for suspected occult fracture, osteonecrosis, or deep infection.
Management Principles
Initial care includes joint immobilization in a position of comfort, vascular access, analgesia, and early aspiration. Septic arthritis requires immediate empiric intravenous antibiotics and urgent orthopedic consultation, often followed by surgical irrigation. Crystalline arthritis management focuses first on controlling the acute flare with NSAIDs, colchicine, or corticosteroids, followed later by prophylactic and urate-lowering therapy once the flare resolves. Noninflammatory causes are managed with analgesia, anti-inflammatory agents, physical therapy, and orthopedic intervention when indicated. Hemorrhagic arthritis requires correction of underlying coagulopathy.
Disposition And Follow-Up
Admission is required for all cases of septic arthritis, patients unable to perform activities of daily living, those with systemic illness, metabolic derangements, intractable pain, or joints requiring surgical intervention. Discharge may be appropriate when symptoms are controlled, comorbidities are stable, medications are accessible, and reliable follow-up is ensured. Prompt referral to appropriate specialists is essential for definitive management.
Key Clinical Insights And Diagnostic Traps
Synovial fluid aspiration with Gram stain and analysis is the single most important diagnostic step and should not be delayed. Septic arthritis must be assumed until definitively excluded, particularly in patients with diabetes, immunosuppression, recent joint injections, trauma, or overlying cellulitis. Intra-articular corticosteroids should never be administered until infection has been ruled out, as this may worsen outcomes and obscure diagnosis.
- Published on
Emergency and Acute Medicine – Ataxia
Clinical Definition
Ataxia is the inability to perform coordinated voluntary movements and most commonly results from dysfunction of the cerebellum or its neural connections. Lesions of the lateral cerebellar hemispheres produce ipsilateral limb findings, whereas midline lesions result in truncal ataxia.
Etiology And Pathophysiology
Although typically cerebellar in origin, ataxia may also arise from sensory, motor, or vestibular system dysfunction. Causes include trauma, intracranial mass lesions, vascular disorders, infections and postinfectious processes, toxins or medications, metabolic and endocrine derangements, demyelinating disease, congenital malformations, hereditary disorders such as inborn errors of metabolism and progressive degenerative ataxias, as well as nutritional deficiencies.
Clinical Presentation
Gait disturbance is the most common presenting feature and often begins as a subjective sense of imbalance or insecurity while walking. Patients may report difficulty with activities requiring coordination such as bicycling, skiing, or climbing. Examination often reveals a wide-based stance and staggering gait; tandem gait testing is useful for detecting subtle abnormalities. Limb ataxia manifests as incoordination, intention tremor, clumsiness with fine motor tasks, dysmetria on finger-to-nose or heel-to-shin testing, and dysdiadochokinesis during rapid alternating movements. Truncal ataxia may present with head tremor, truncal instability, titubation, and difficulty maintaining posture while seated or standing. Speech abnormalities include slurred, scanning, or staccato dysarthria and bulbar symptoms such as choking from impaired swallowing coordination. Visual complaints may include blurred vision or vertigo; central vertigo must be distinguished from peripheral causes, which are typically severe, positional, and associated with ear symptoms. Nystagmus may be gaze-evoked or rebound in nature. Cerebellar disease rarely causes true muscle weakness or hypotonia, though isometrataxia may be demonstrated by inability to sustain constant force. Sensory ataxia presents with paresthesias, numbness, a cautious steppage gait, loss of position or vibration sense, and marked worsening with eye closure, producing a positive Romberg sign.
History And Examination
A careful history is essential, as gait disturbance may reflect pain, weakness, lightheadedness, vertigo, or incoordination rather than true ataxia. Determine onset and progression, distinguishing acute (hours to days), subacute (weeks to months), and chronic (months to years) presentations. Assess for symmetry or focality of symptoms, associated fever, altered mental status, weakness, sensory loss, urinary incontinence, recent infections or immunizations, trauma, toxic exposures, and family history of movement disorders. Physical examination should include a complete neurologic and gait assessment, with careful evaluation for life-threatening conditions such as stroke, hemorrhage, CNS infection, or elevated intracranial pressure manifested by headache, papilledema, bradycardia, hypertension, abnormal respirations, bulging fontanelles, nausea, vomiting, or meningismus. Ear examination and provocative testing for nystagmus may help identify vestibular pathology. Intoxication and toxidromes should be considered when ingestion is suspected.
Diagnostic Evaluation
Workup is guided by history and examination. Basic laboratory testing includes blood glucose, serum electrolytes, thyroid function tests, and targeted toxicology screening, recognizing that standard panels may miss relevant agents. Imaging is critical when central causes are suspected. Head CT can identify hemorrhage, mass lesions, hydrocephalus, or subacute infarction, though sensitivity for posterior fossa pathology is limited. CT with contrast or CT angiography may be indicated when mass or vascular disease is suspected. MRI is superior for evaluating posterior fossa lesions, acute ischemia, demyelination, and vascular abnormalities, and MR angiography may be required for suspected vascular etiologies. Lumbar puncture is indicated when infection or Guillain–Barré syndrome is suspected. Electrocardiography is not routinely required but may assist in evaluating nonspecific dizziness.
Differential Diagnosis
Acute symmetric ataxia includes head trauma, drug or toxin exposure such as alcohol, lithium, phenytoin, barbiturates, carbamazepine, phenobarbital, valproic acid, benzodiazepines, diphenhydramine, or dextromethorphan, acute viral cerebellitis, meningitis or encephalitis, hydrocephalus, postinfectious syndromes, hypoglycemia, hyponatremia, and severe heat stroke. Acute focal ataxia suggests posterior circulation infarction, vertebrobasilar insufficiency, cerebellar hemorrhage, subdural hematoma, cerebellar abscess, acute disseminated encephalomyelitis, complicated migraine, or atypical seizure. Subacute symmetric ataxia may result from heavy metals, hydrocarbons, chemotherapy, organophosphates, vitamin B1 or B12 deficiency, paraneoplastic syndromes, Lyme disease, toxoplasmosis, or Creutzfeldt–Jakob disease. Subacute focal ataxia includes cerebellar glioma, metastases, lymphoma, multiple sclerosis, Guillain–Barré syndrome, AIDS-related progressive multifocal leukoencephalopathy, syringomyelia, or cervical spondylosis. Chronic ataxia may reflect alcohol-related cerebellar degeneration, inherited disorders such as spinocerebellar ataxias, Friedreich ataxia, ataxia telangiectasia, Niemann–Pick disease, hypothyroidism, vitamin E deficiency, tabes dorsalis, or congenital malformations including Arnold–Chiari and Dandy–Walker syndromes. Peripheral vestibular disorders may mimic ataxic gait.
Special Populations
Children may present with refusal to walk. Acute pediatric ataxia is often benign and self-limited, most commonly due to acute cerebellar ataxia or drug ingestion. Postinfectious acute cerebellar ataxia typically affects children aged 2–5 years, occurs 1–3 weeks after illness or immunization, features normal mental status, and resolves within three months. Toxic ingestions often produce mental status changes. Guillain–Barré syndrome may present with sensory ataxia, particularly in the Miller–Fisher variant. Brain tumors frequently involve the cerebellum or brainstem, and opsoclonus–myoclonus–ataxia syndrome is strongly associated with neuroblastoma. Stroke is rare in children but occurs in those with sickle cell disease or hypercoagulable states. In elderly patients, gait disorders are frequently multifactorial, and posterior circulation stroke or vertebrobasilar insufficiency may present with vague symptoms such as dizziness.
Emergency Management
Acute onset ataxia should prompt concern for stroke or hemorrhage. Initial stabilization includes airway, breathing, and circulation, IV access, supplemental oxygen, cardiac monitoring, and immediate blood glucose assessment with dextrose administration for hypoglycemia. Thiamine should be given to malnourished or alcoholic patients. Fall precautions are essential. Management is directed at the underlying cause; cerebellar infarction may cause rapid edema with mass effect and require urgent neurosurgical consultation for decompression.
Medications
Administer dextrose for hypoglycemia and thiamine when indicated. Additional therapies are etiology-specific.
Disposition
Admission is indicated for acute or subacute ataxia when a benign cause cannot be confidently established, inability to ambulate safely, or evidence of cerebellar hemorrhage or mass effect, which requires ICU care. Discharge may be considered for patients with mild or reversible symptoms, normal mental status, and safe ambulation.
Follow-Up
Arrange follow-up with primary care or neurology based on the suspected etiology.
Clinical Lessons And Safety Points
Common errors include failing to distinguish true ataxia from other gait disturbances, overlooking trauma in intoxicated patients, overreliance on CT for posterior fossa evaluation, and underestimating the risk of herniation from cerebellar lesions such as stroke.
Clinical Definition
Ataxia is the inability to perform coordinated voluntary movements and most commonly results from dysfunction of the cerebellum or its neural connections. Lesions of the lateral cerebellar hemispheres produce ipsilateral limb findings, whereas midline lesions result in truncal ataxia.
Etiology And Pathophysiology
Although typically cerebellar in origin, ataxia may also arise from sensory, motor, or vestibular system dysfunction. Causes include trauma, intracranial mass lesions, vascular disorders, infections and postinfectious processes, toxins or medications, metabolic and endocrine derangements, demyelinating disease, congenital malformations, hereditary disorders such as inborn errors of metabolism and progressive degenerative ataxias, as well as nutritional deficiencies.
Clinical Presentation
Gait disturbance is the most common presenting feature and often begins as a subjective sense of imbalance or insecurity while walking. Patients may report difficulty with activities requiring coordination such as bicycling, skiing, or climbing. Examination often reveals a wide-based stance and staggering gait; tandem gait testing is useful for detecting subtle abnormalities. Limb ataxia manifests as incoordination, intention tremor, clumsiness with fine motor tasks, dysmetria on finger-to-nose or heel-to-shin testing, and dysdiadochokinesis during rapid alternating movements. Truncal ataxia may present with head tremor, truncal instability, titubation, and difficulty maintaining posture while seated or standing. Speech abnormalities include slurred, scanning, or staccato dysarthria and bulbar symptoms such as choking from impaired swallowing coordination. Visual complaints may include blurred vision or vertigo; central vertigo must be distinguished from peripheral causes, which are typically severe, positional, and associated with ear symptoms. Nystagmus may be gaze-evoked or rebound in nature. Cerebellar disease rarely causes true muscle weakness or hypotonia, though isometrataxia may be demonstrated by inability to sustain constant force. Sensory ataxia presents with paresthesias, numbness, a cautious steppage gait, loss of position or vibration sense, and marked worsening with eye closure, producing a positive Romberg sign.
History And Examination
A careful history is essential, as gait disturbance may reflect pain, weakness, lightheadedness, vertigo, or incoordination rather than true ataxia. Determine onset and progression, distinguishing acute (hours to days), subacute (weeks to months), and chronic (months to years) presentations. Assess for symmetry or focality of symptoms, associated fever, altered mental status, weakness, sensory loss, urinary incontinence, recent infections or immunizations, trauma, toxic exposures, and family history of movement disorders. Physical examination should include a complete neurologic and gait assessment, with careful evaluation for life-threatening conditions such as stroke, hemorrhage, CNS infection, or elevated intracranial pressure manifested by headache, papilledema, bradycardia, hypertension, abnormal respirations, bulging fontanelles, nausea, vomiting, or meningismus. Ear examination and provocative testing for nystagmus may help identify vestibular pathology. Intoxication and toxidromes should be considered when ingestion is suspected.
Diagnostic Evaluation
Workup is guided by history and examination. Basic laboratory testing includes blood glucose, serum electrolytes, thyroid function tests, and targeted toxicology screening, recognizing that standard panels may miss relevant agents. Imaging is critical when central causes are suspected. Head CT can identify hemorrhage, mass lesions, hydrocephalus, or subacute infarction, though sensitivity for posterior fossa pathology is limited. CT with contrast or CT angiography may be indicated when mass or vascular disease is suspected. MRI is superior for evaluating posterior fossa lesions, acute ischemia, demyelination, and vascular abnormalities, and MR angiography may be required for suspected vascular etiologies. Lumbar puncture is indicated when infection or Guillain–Barré syndrome is suspected. Electrocardiography is not routinely required but may assist in evaluating nonspecific dizziness.
Differential Diagnosis
Acute symmetric ataxia includes head trauma, drug or toxin exposure such as alcohol, lithium, phenytoin, barbiturates, carbamazepine, phenobarbital, valproic acid, benzodiazepines, diphenhydramine, or dextromethorphan, acute viral cerebellitis, meningitis or encephalitis, hydrocephalus, postinfectious syndromes, hypoglycemia, hyponatremia, and severe heat stroke. Acute focal ataxia suggests posterior circulation infarction, vertebrobasilar insufficiency, cerebellar hemorrhage, subdural hematoma, cerebellar abscess, acute disseminated encephalomyelitis, complicated migraine, or atypical seizure. Subacute symmetric ataxia may result from heavy metals, hydrocarbons, chemotherapy, organophosphates, vitamin B1 or B12 deficiency, paraneoplastic syndromes, Lyme disease, toxoplasmosis, or Creutzfeldt–Jakob disease. Subacute focal ataxia includes cerebellar glioma, metastases, lymphoma, multiple sclerosis, Guillain–Barré syndrome, AIDS-related progressive multifocal leukoencephalopathy, syringomyelia, or cervical spondylosis. Chronic ataxia may reflect alcohol-related cerebellar degeneration, inherited disorders such as spinocerebellar ataxias, Friedreich ataxia, ataxia telangiectasia, Niemann–Pick disease, hypothyroidism, vitamin E deficiency, tabes dorsalis, or congenital malformations including Arnold–Chiari and Dandy–Walker syndromes. Peripheral vestibular disorders may mimic ataxic gait.
Special Populations
Children may present with refusal to walk. Acute pediatric ataxia is often benign and self-limited, most commonly due to acute cerebellar ataxia or drug ingestion. Postinfectious acute cerebellar ataxia typically affects children aged 2–5 years, occurs 1–3 weeks after illness or immunization, features normal mental status, and resolves within three months. Toxic ingestions often produce mental status changes. Guillain–Barré syndrome may present with sensory ataxia, particularly in the Miller–Fisher variant. Brain tumors frequently involve the cerebellum or brainstem, and opsoclonus–myoclonus–ataxia syndrome is strongly associated with neuroblastoma. Stroke is rare in children but occurs in those with sickle cell disease or hypercoagulable states. In elderly patients, gait disorders are frequently multifactorial, and posterior circulation stroke or vertebrobasilar insufficiency may present with vague symptoms such as dizziness.
Emergency Management
Acute onset ataxia should prompt concern for stroke or hemorrhage. Initial stabilization includes airway, breathing, and circulation, IV access, supplemental oxygen, cardiac monitoring, and immediate blood glucose assessment with dextrose administration for hypoglycemia. Thiamine should be given to malnourished or alcoholic patients. Fall precautions are essential. Management is directed at the underlying cause; cerebellar infarction may cause rapid edema with mass effect and require urgent neurosurgical consultation for decompression.
Medications
Administer dextrose for hypoglycemia and thiamine when indicated. Additional therapies are etiology-specific.
Disposition
Admission is indicated for acute or subacute ataxia when a benign cause cannot be confidently established, inability to ambulate safely, or evidence of cerebellar hemorrhage or mass effect, which requires ICU care. Discharge may be considered for patients with mild or reversible symptoms, normal mental status, and safe ambulation.
Follow-Up
Arrange follow-up with primary care or neurology based on the suspected etiology.
Clinical Lessons And Safety Points
Common errors include failing to distinguish true ataxia from other gait disturbances, overlooking trauma in intoxicated patients, overreliance on CT for posterior fossa evaluation, and underestimating the risk of herniation from cerebellar lesions such as stroke.
- Published on
Emergency and Acute Medicine – Asystole
Clinical Definition
Asystole is the complete absence of ventricular electrical activity.
Causes And Pathophysiology
Asystole is typically a terminal rhythm and may evolve from prolonged bradycardia, prolonged ventricular fibrillation, or prolonged pulseless electrical activity. Survival is extremely unlikely when asystole occurs out of hospital; roughly 40% may achieve return of spontaneous circulation and survive to hospital admission, but fewer than 15% survive to hospital discharge. Prognosis is similarly poor when asystole develops after countershock for ventricular tachycardia or ventricular fibrillation, with fewer than 10% surviving to hospital discharge. Potentially reversible causes include hypoxia, hypovolemia from blood loss, acidosis, hyperkalemia, hypokalemia, drug overdose, hypothermia, pulmonary embolism, myocardial infarction, tension pneumothorax, and cardiac tamponade.
Clinical Presentation
Patients are unresponsive, pulseless, and may have agonal respirations or no spontaneous breathing.
Immediate Assessment Priorities
Confirm true asystole in two limb leads to avoid mistaking fine ventricular fibrillation for asystole. Check lead and cable connections, ensure the monitor is powered on, and verify the gain is adequately increased. Actively look for reversible causes while resuscitation is ongoing.
Investigations In The ED
Arterial blood gas analysis may assist, particularly for potassium and hemoglobin assessment. Bedside cardiac ultrasound is useful to evaluate for pericardial tamponade.
Key Alternative Diagnosis
Fine ventricular fibrillation can mimic asystole and must be excluded.
Prehospital Considerations
No intervention should be performed if a valid Do Not Resuscitate order is present. Resuscitation should not be initiated when death is verifiable by rigor mortis, dependent livedo, or injuries incompatible with life such as decapitation.
Resuscitation Approach
Begin CPR immediately with emphasis on high-quality chest compressions with minimal interruptions. Confirm asystole on the cardiac monitor. Secure the airway using an endotracheal tube when feasible, though bag-valve-mask ventilation is acceptable, then confirm placement and provide 100% inspired oxygen while ventilating slowly at 6–12 breaths per minute. Limit pauses in compressions during airway placement. Establish IV or intraosseous access. Use continuous waveform capnography to guide and optimize compression quality; end-tidal CO₂ correlates with cardiac output and myocardial blood flow during CPR. Administer epinephrine every 3–5 minutes. Search for and treat reversible causes without delay. Sodium bicarbonate is reserved for suspected hyperkalemia or drug overdose. There is no proven benefit to giving an empiric single countershock, and no proven benefit to electrical pacing in asystole. If the rhythm converts to ventricular fibrillation or ventricular tachycardia, defibrillate immediately without delay.
Post-ROSC Care And ED Management
If return of spontaneous circulation occurs and the patient remains comatose, initiate induced hypothermia as part of post–cardiac arrest care. Consider termination of resuscitation only when high-quality compressions have been delivered for an adequate period, the trachea has been intubated to ensure oxygenation, fine ventricular fibrillation has been excluded, reversible causes have been corrected or ruled out, bedside ultrasound shows no pericardial effusion, and there is no clinical evidence of tension pneumothorax.
Medications
Epinephrine is given as 1 mg IV every 3–5 minutes in adults, and 0.01 mg/kg IV every 3–5 minutes in children. Sodium bicarbonate is dosed at 1 mEq/kg IV and should be used only when there is pre-existing acidosis, suspected hyperkalemia, or suspected tricyclic antidepressant overdose.
Disposition And Monitoring
Any patient with return of spontaneous circulation requires admission, and there are no discharge pathways from the ED after asystolic arrest. Post-arrest care should occur in an ICU with cardiac monitoring and induced hypothermia when indicated.
Follow-Up Planning
A permanent pacemaker may be considered only when asystole is determined to be due to primary heart block.
Clinical Lessons And Safety Points
Outcomes depend heavily on immediate, minimally interrupted, high-quality chest compressions while aggressively searching for reversible causes. Successful resuscitation is most likely only when a reversible cause is identified and corrected promptly.
Clinical Definition
Asystole is the complete absence of ventricular electrical activity.
Causes And Pathophysiology
Asystole is typically a terminal rhythm and may evolve from prolonged bradycardia, prolonged ventricular fibrillation, or prolonged pulseless electrical activity. Survival is extremely unlikely when asystole occurs out of hospital; roughly 40% may achieve return of spontaneous circulation and survive to hospital admission, but fewer than 15% survive to hospital discharge. Prognosis is similarly poor when asystole develops after countershock for ventricular tachycardia or ventricular fibrillation, with fewer than 10% surviving to hospital discharge. Potentially reversible causes include hypoxia, hypovolemia from blood loss, acidosis, hyperkalemia, hypokalemia, drug overdose, hypothermia, pulmonary embolism, myocardial infarction, tension pneumothorax, and cardiac tamponade.
Clinical Presentation
Patients are unresponsive, pulseless, and may have agonal respirations or no spontaneous breathing.
Immediate Assessment Priorities
Confirm true asystole in two limb leads to avoid mistaking fine ventricular fibrillation for asystole. Check lead and cable connections, ensure the monitor is powered on, and verify the gain is adequately increased. Actively look for reversible causes while resuscitation is ongoing.
Investigations In The ED
Arterial blood gas analysis may assist, particularly for potassium and hemoglobin assessment. Bedside cardiac ultrasound is useful to evaluate for pericardial tamponade.
Key Alternative Diagnosis
Fine ventricular fibrillation can mimic asystole and must be excluded.
Prehospital Considerations
No intervention should be performed if a valid Do Not Resuscitate order is present. Resuscitation should not be initiated when death is verifiable by rigor mortis, dependent livedo, or injuries incompatible with life such as decapitation.
Resuscitation Approach
Begin CPR immediately with emphasis on high-quality chest compressions with minimal interruptions. Confirm asystole on the cardiac monitor. Secure the airway using an endotracheal tube when feasible, though bag-valve-mask ventilation is acceptable, then confirm placement and provide 100% inspired oxygen while ventilating slowly at 6–12 breaths per minute. Limit pauses in compressions during airway placement. Establish IV or intraosseous access. Use continuous waveform capnography to guide and optimize compression quality; end-tidal CO₂ correlates with cardiac output and myocardial blood flow during CPR. Administer epinephrine every 3–5 minutes. Search for and treat reversible causes without delay. Sodium bicarbonate is reserved for suspected hyperkalemia or drug overdose. There is no proven benefit to giving an empiric single countershock, and no proven benefit to electrical pacing in asystole. If the rhythm converts to ventricular fibrillation or ventricular tachycardia, defibrillate immediately without delay.
Post-ROSC Care And ED Management
If return of spontaneous circulation occurs and the patient remains comatose, initiate induced hypothermia as part of post–cardiac arrest care. Consider termination of resuscitation only when high-quality compressions have been delivered for an adequate period, the trachea has been intubated to ensure oxygenation, fine ventricular fibrillation has been excluded, reversible causes have been corrected or ruled out, bedside ultrasound shows no pericardial effusion, and there is no clinical evidence of tension pneumothorax.
Medications
Epinephrine is given as 1 mg IV every 3–5 minutes in adults, and 0.01 mg/kg IV every 3–5 minutes in children. Sodium bicarbonate is dosed at 1 mEq/kg IV and should be used only when there is pre-existing acidosis, suspected hyperkalemia, or suspected tricyclic antidepressant overdose.
Disposition And Monitoring
Any patient with return of spontaneous circulation requires admission, and there are no discharge pathways from the ED after asystolic arrest. Post-arrest care should occur in an ICU with cardiac monitoring and induced hypothermia when indicated.
Follow-Up Planning
A permanent pacemaker may be considered only when asystole is determined to be due to primary heart block.
Clinical Lessons And Safety Points
Outcomes depend heavily on immediate, minimally interrupted, high-quality chest compressions while aggressively searching for reversible causes. Successful resuscitation is most likely only when a reversible cause is identified and corrected promptly.
- Published on
Emergency and Acute Medicine – Rheumatoid Arthritis
Clinical Overview
Rheumatoid arthritis is a chronic, systemic inflammatory disease characterized by persistent, noninfectious synovitis that leads to progressive destruction of articular cartilage, joint deformity, and eventual ankylosis. The disease most commonly affects peripheral joints in a symmetric pattern and is associated with significant extra-articular involvement. Knee involvement is frequent, and chronic inflammation may result in Baker cyst formation. Axial disease is typically limited to the cervical spine, where atlantoaxial subluxation may occur and, rarely, cause spinal cord compression. Rheumatoid arthritis is distinct from juvenile idiopathic arthritis, which represents a separate pediatric condition.
Epidemiology And Pathogenesis
The etiology remains unknown, though autoimmune mechanisms likely triggered by environmental factors in genetically predisposed individuals are implicated. An association with HLA-DR4 has been identified. The condition affects approximately 1% of the global population, with a female predominance of roughly 3:1. Onset most commonly occurs between 30 and 50 years of age.
Clinical Manifestations
Early symptoms are often nonspecific and include fatigue, malaise, and diffuse musculoskeletal discomfort. Over weeks to months, patients develop warm, swollen, painful joints, classically worse in the morning with stiffness lasting longer than one hour. Joint involvement is usually symmetric and polyarticular, beginning in the small joints of the hands and feet and later involving the wrists, elbows, and knees. Distal interphalangeal joint involvement is uncommon and should prompt consideration of alternative diagnoses. Synovitis progresses gradually, and long-standing disease leads to characteristic deformities such as ulnar deviation of the metacarpophalangeal joints, swan-neck deformities, and boutonnière deformities.
Extra-articular manifestations are common and include subcutaneous rheumatoid nodules, vasculitis, pericarditis or myocarditis, pulmonary fibrosis or pneumonitis, Sjögren syndrome, and mononeuritis multiplex. Mild pericarditis may be present in a significant proportion of patients and may warrant electrocardiographic evaluation. Emergency department presentations often relate to disease flares or complications affecting other organ systems, including airway compromise from cricoarytenoid arthritis, cardiac conduction abnormalities, pulmonary disease, hepatic involvement, or neurologic deficits related to cervical spine instability. Ocular complications such as scleritis, episcleritis, iritis, or retinal vasculitis should be suspected in patients with red eye, photophobia, or vision changes and require urgent ophthalmologic evaluation. Chronic medication use may result in infections, osteopenia, fractures, metabolic disturbances, glaucoma, cataracts, or gastrointestinal bleeding.
Diagnostic Approach In The Emergency Setting
A definitive diagnosis of rheumatoid arthritis is rarely established in the emergency department. Diagnostic criteria require synovitis lasting at least six weeks and fulfillment of established classification criteria. Emergency evaluation should instead focus on excluding alternative or immediately life-threatening causes of arthritis, particularly septic arthritis, gout, or reactive arthritis. Arthrocentesis is indicated when infection or crystal-induced disease is a concern. A careful history should assess systemic symptoms such as weight loss, fever, weakness, bursitis, or tendonitis.
Laboratory And Imaging Evaluation
Laboratory studies may reveal mild anemia, leukocytosis, thrombocytosis, elevated erythrocyte sedimentation rate, and increased C-reactive protein, which correlates with erosive disease. Rheumatoid factor is positive in the majority of patients, while antinuclear antibodies may be present in a subset. Synovial fluid analysis typically shows an inflammatory profile with elevated white blood cell counts and neutrophil predominance, without organisms or crystals. Imaging may demonstrate joint effusions, juxta-articular erosions, joint space narrowing, and loss of cartilage. MRI can detect early inflammatory changes before radiographic abnormalities. Chest imaging may reveal pulmonary or cardiac involvement, and cervical spine imaging is important when neurologic symptoms or airway concerns are present.
Management Principles
Prehospital and emergency care priorities include airway management with cervical spine protection when indicated and treatment of acute complications. Nonsteroidal anti-inflammatory drugs and salicylates are first-line agents for symptom control in acute settings, recognizing that early disease may progress rapidly. Glucocorticoids, disease-modifying antirheumatic drugs, and biologic agents should generally be initiated or adjusted in consultation with a rheumatologist rather than started de novo in the emergency department. Pain control and supportive care are essential, while careful attention must be paid to medication side effects and comorbid conditions.
Disposition And Follow-Up
Hospital admission is warranted for patients with severe or life-threatening complications, unclear diagnoses where serious alternative conditions cannot be excluded, uncontrolled pain, significant functional impairment, or inadequate social support. Pediatric patients presenting with fever and arthritis require a low threshold for admission. Stable patients without complications may be discharged with appropriate outpatient management and close follow-up. Ongoing care should involve coordination with primary care and specialty services, including rheumatology, cardiology, ophthalmology, and orthopedics as indicated.
Clinical Insights And Diagnostic Pitfalls
Symmetric inflammatory arthritis strongly suggests rheumatoid arthritis, but the presence of this diagnosis does not exclude superimposed septic arthritis, which must always be considered. Disease-modifying therapies and biologic agents should not be initiated in the emergency department without specialist input. Careful evaluation for cervical spine instability and extra-articular complications is essential, as these may present with subtle but high-risk features.
Clinical Overview
Rheumatoid arthritis is a chronic, systemic inflammatory disease characterized by persistent, noninfectious synovitis that leads to progressive destruction of articular cartilage, joint deformity, and eventual ankylosis. The disease most commonly affects peripheral joints in a symmetric pattern and is associated with significant extra-articular involvement. Knee involvement is frequent, and chronic inflammation may result in Baker cyst formation. Axial disease is typically limited to the cervical spine, where atlantoaxial subluxation may occur and, rarely, cause spinal cord compression. Rheumatoid arthritis is distinct from juvenile idiopathic arthritis, which represents a separate pediatric condition.
Epidemiology And Pathogenesis
The etiology remains unknown, though autoimmune mechanisms likely triggered by environmental factors in genetically predisposed individuals are implicated. An association with HLA-DR4 has been identified. The condition affects approximately 1% of the global population, with a female predominance of roughly 3:1. Onset most commonly occurs between 30 and 50 years of age.
Clinical Manifestations
Early symptoms are often nonspecific and include fatigue, malaise, and diffuse musculoskeletal discomfort. Over weeks to months, patients develop warm, swollen, painful joints, classically worse in the morning with stiffness lasting longer than one hour. Joint involvement is usually symmetric and polyarticular, beginning in the small joints of the hands and feet and later involving the wrists, elbows, and knees. Distal interphalangeal joint involvement is uncommon and should prompt consideration of alternative diagnoses. Synovitis progresses gradually, and long-standing disease leads to characteristic deformities such as ulnar deviation of the metacarpophalangeal joints, swan-neck deformities, and boutonnière deformities.
Extra-articular manifestations are common and include subcutaneous rheumatoid nodules, vasculitis, pericarditis or myocarditis, pulmonary fibrosis or pneumonitis, Sjögren syndrome, and mononeuritis multiplex. Mild pericarditis may be present in a significant proportion of patients and may warrant electrocardiographic evaluation. Emergency department presentations often relate to disease flares or complications affecting other organ systems, including airway compromise from cricoarytenoid arthritis, cardiac conduction abnormalities, pulmonary disease, hepatic involvement, or neurologic deficits related to cervical spine instability. Ocular complications such as scleritis, episcleritis, iritis, or retinal vasculitis should be suspected in patients with red eye, photophobia, or vision changes and require urgent ophthalmologic evaluation. Chronic medication use may result in infections, osteopenia, fractures, metabolic disturbances, glaucoma, cataracts, or gastrointestinal bleeding.
Diagnostic Approach In The Emergency Setting
A definitive diagnosis of rheumatoid arthritis is rarely established in the emergency department. Diagnostic criteria require synovitis lasting at least six weeks and fulfillment of established classification criteria. Emergency evaluation should instead focus on excluding alternative or immediately life-threatening causes of arthritis, particularly septic arthritis, gout, or reactive arthritis. Arthrocentesis is indicated when infection or crystal-induced disease is a concern. A careful history should assess systemic symptoms such as weight loss, fever, weakness, bursitis, or tendonitis.
Laboratory And Imaging Evaluation
Laboratory studies may reveal mild anemia, leukocytosis, thrombocytosis, elevated erythrocyte sedimentation rate, and increased C-reactive protein, which correlates with erosive disease. Rheumatoid factor is positive in the majority of patients, while antinuclear antibodies may be present in a subset. Synovial fluid analysis typically shows an inflammatory profile with elevated white blood cell counts and neutrophil predominance, without organisms or crystals. Imaging may demonstrate joint effusions, juxta-articular erosions, joint space narrowing, and loss of cartilage. MRI can detect early inflammatory changes before radiographic abnormalities. Chest imaging may reveal pulmonary or cardiac involvement, and cervical spine imaging is important when neurologic symptoms or airway concerns are present.
Management Principles
Prehospital and emergency care priorities include airway management with cervical spine protection when indicated and treatment of acute complications. Nonsteroidal anti-inflammatory drugs and salicylates are first-line agents for symptom control in acute settings, recognizing that early disease may progress rapidly. Glucocorticoids, disease-modifying antirheumatic drugs, and biologic agents should generally be initiated or adjusted in consultation with a rheumatologist rather than started de novo in the emergency department. Pain control and supportive care are essential, while careful attention must be paid to medication side effects and comorbid conditions.
Disposition And Follow-Up
Hospital admission is warranted for patients with severe or life-threatening complications, unclear diagnoses where serious alternative conditions cannot be excluded, uncontrolled pain, significant functional impairment, or inadequate social support. Pediatric patients presenting with fever and arthritis require a low threshold for admission. Stable patients without complications may be discharged with appropriate outpatient management and close follow-up. Ongoing care should involve coordination with primary care and specialty services, including rheumatology, cardiology, ophthalmology, and orthopedics as indicated.
Clinical Insights And Diagnostic Pitfalls
Symmetric inflammatory arthritis strongly suggests rheumatoid arthritis, but the presence of this diagnosis does not exclude superimposed septic arthritis, which must always be considered. Disease-modifying therapies and biologic agents should not be initiated in the emergency department without specialist input. Careful evaluation for cervical spine instability and extra-articular complications is essential, as these may present with subtle but high-risk features.
- Published on
Emergency and Acute Medicine – Adult Asthma
Clinical Overview
Adult asthma is a chronic inflammatory airway disorder characterized by increased expiratory resistance due to bronchospasm, mucosal edema, airway inflammation, mucus plugging, and smooth muscle hypertrophy. These processes lead to air trapping, hyperinflation, increased dead space, and progressive airway remodeling. Status asthmaticus refers to a severe exacerbation that fails to respond to standard therapy within 30–60 minutes. Patients at highest risk for life-threatening episodes include those with prior intubations or ICU admissions, chronic systemic steroid use, recent hospitalizations, poor outpatient control, advancing age, limited access to care, multiple comorbidities, and certain demographic factors.
Pathophysiology And Triggers
Asthma involves episodic and usually reversible airflow obstruction with airway hyperresponsiveness driven by a complex inflammatory cascade. Neutrophils, eosinophils, mast cells, macrophages, T lymphocytes, epithelial cells, and cytokines all contribute. Common triggers include environmental allergens such as pollen, dust mites, mold, and animal dander; viral upper respiratory infections; occupational or chemical exposures; tobacco smoke; cold air; exercise; emotional stress; hormonal variation; and medications including aspirin, NSAIDs, and beta-blockers.
Clinical Presentation
Typical symptoms include wheezing, dyspnea, chest tightness, cough, tachypnea, and tachycardia. More severe exacerbations manifest with upright or tripod positioning, accessory muscle use, diaphoresis, inability to speak full sentences, and diminished air movement. Signs of impending respiratory failure include altered mental status, extreme fatigue, and significant pulsus paradoxus.
Diagnostic Assessment
Asthma exacerbation is primarily a clinical diagnosis. Peak expiratory flow rate is useful for quantifying severity and monitoring response to therapy, with values below 100 indicating severe obstruction and values between 100 and 300 reflecting moderate disease. Serial measurements are more informative than single readings. Arterial blood gas testing is not routinely required and should not delay intervention; rising carbon dioxide levels and respiratory acidosis signal exhaustion and impending failure. Pulse oximetry values below 90 percent suggest severe distress, though normal saturation does not exclude imminent collapse. Chest radiography is reserved for selected cases such as suspected pneumonia, pneumothorax, foreign body aspiration, first-time wheezing, or poor response to therapy. ECG is considered when cardiac disease or significant tachyarrhythmia is suspected.
Differential Considerations
Conditions that may mimic asthma include allergic reactions, angioedema, COPD exacerbation, heart failure, pulmonary embolism, pneumonia, upper airway obstruction, foreign body aspiration, myocardial ischemia, and inhalational injury.
Initial Management Principles
Early recognition of severe disease, including the presence of a “quiet chest,” is critical. Immediate therapy includes supplemental oxygen, rapid initiation of inhaled beta-agonists, and early systemic corticosteroids. Intubation should be considered for progressive fatigue, worsening mental status, or refractory hypoxemia.
Emergency Department Management
Oxygen therapy should maintain saturation above 90 percent. Short-acting inhaled beta-2 agonists such as albuterol are first-line and may be administered intermittently for mild to moderate attacks or continuously for severe exacerbations. Subcutaneous beta-agonists may be used when inhaled therapy is inadequate but carry greater systemic risk. Systemic corticosteroids reduce airway inflammation and should be administered early despite delayed onset of action. Anticholinergic agents are beneficial when added to beta-agonists in moderate to severe obstruction. Magnesium sulfate may provide benefit in severe refractory asthma but is not indicated in mild disease. Aminophylline and leukotriene inhibitors are generally not recommended in the acute setting. Noninvasive ventilation and heliox may be considered selectively but should not delay definitive airway management. Ketamine is useful as an induction agent during intubation due to bronchodilatory properties, while permissive hypercapnia may be required during mechanical ventilation.
Disposition And Follow-Up
Hospital admission is indicated for patients with poor peak flow response, persistent respiratory distress, prior severe exacerbations, recent ED visits, prolonged symptoms, or inadequate outpatient support. Observation may be appropriate for moderate responders without distress. Discharge is reasonable when peak flow exceeds 70 percent of predicted, symptoms have clearly improved, lung examination demonstrates good air movement, and close follow-up within 48–72 hours is ensured.
Key Clinical Lessons And Safety Points
Altered mental status in an asthmatic patient signifies ventilatory failure until proven otherwise. Proper inhaler or nebulizer technique must be demonstrated prior to discharge, and peak flow monitoring should be encouraged. Routine intravenous fluids do not improve airway clearance in the absence of dehydration. Antibiotics are rarely indicated and should be reserved for clear evidence of bacterial infection such as pneumonia, fever with purulent sputum, or bacterial sinusitis.
Clinical Overview
Adult asthma is a chronic inflammatory airway disorder characterized by increased expiratory resistance due to bronchospasm, mucosal edema, airway inflammation, mucus plugging, and smooth muscle hypertrophy. These processes lead to air trapping, hyperinflation, increased dead space, and progressive airway remodeling. Status asthmaticus refers to a severe exacerbation that fails to respond to standard therapy within 30–60 minutes. Patients at highest risk for life-threatening episodes include those with prior intubations or ICU admissions, chronic systemic steroid use, recent hospitalizations, poor outpatient control, advancing age, limited access to care, multiple comorbidities, and certain demographic factors.
Pathophysiology And Triggers
Asthma involves episodic and usually reversible airflow obstruction with airway hyperresponsiveness driven by a complex inflammatory cascade. Neutrophils, eosinophils, mast cells, macrophages, T lymphocytes, epithelial cells, and cytokines all contribute. Common triggers include environmental allergens such as pollen, dust mites, mold, and animal dander; viral upper respiratory infections; occupational or chemical exposures; tobacco smoke; cold air; exercise; emotional stress; hormonal variation; and medications including aspirin, NSAIDs, and beta-blockers.
Clinical Presentation
Typical symptoms include wheezing, dyspnea, chest tightness, cough, tachypnea, and tachycardia. More severe exacerbations manifest with upright or tripod positioning, accessory muscle use, diaphoresis, inability to speak full sentences, and diminished air movement. Signs of impending respiratory failure include altered mental status, extreme fatigue, and significant pulsus paradoxus.
Diagnostic Assessment
Asthma exacerbation is primarily a clinical diagnosis. Peak expiratory flow rate is useful for quantifying severity and monitoring response to therapy, with values below 100 indicating severe obstruction and values between 100 and 300 reflecting moderate disease. Serial measurements are more informative than single readings. Arterial blood gas testing is not routinely required and should not delay intervention; rising carbon dioxide levels and respiratory acidosis signal exhaustion and impending failure. Pulse oximetry values below 90 percent suggest severe distress, though normal saturation does not exclude imminent collapse. Chest radiography is reserved for selected cases such as suspected pneumonia, pneumothorax, foreign body aspiration, first-time wheezing, or poor response to therapy. ECG is considered when cardiac disease or significant tachyarrhythmia is suspected.
Differential Considerations
Conditions that may mimic asthma include allergic reactions, angioedema, COPD exacerbation, heart failure, pulmonary embolism, pneumonia, upper airway obstruction, foreign body aspiration, myocardial ischemia, and inhalational injury.
Initial Management Principles
Early recognition of severe disease, including the presence of a “quiet chest,” is critical. Immediate therapy includes supplemental oxygen, rapid initiation of inhaled beta-agonists, and early systemic corticosteroids. Intubation should be considered for progressive fatigue, worsening mental status, or refractory hypoxemia.
Emergency Department Management
Oxygen therapy should maintain saturation above 90 percent. Short-acting inhaled beta-2 agonists such as albuterol are first-line and may be administered intermittently for mild to moderate attacks or continuously for severe exacerbations. Subcutaneous beta-agonists may be used when inhaled therapy is inadequate but carry greater systemic risk. Systemic corticosteroids reduce airway inflammation and should be administered early despite delayed onset of action. Anticholinergic agents are beneficial when added to beta-agonists in moderate to severe obstruction. Magnesium sulfate may provide benefit in severe refractory asthma but is not indicated in mild disease. Aminophylline and leukotriene inhibitors are generally not recommended in the acute setting. Noninvasive ventilation and heliox may be considered selectively but should not delay definitive airway management. Ketamine is useful as an induction agent during intubation due to bronchodilatory properties, while permissive hypercapnia may be required during mechanical ventilation.
Disposition And Follow-Up
Hospital admission is indicated for patients with poor peak flow response, persistent respiratory distress, prior severe exacerbations, recent ED visits, prolonged symptoms, or inadequate outpatient support. Observation may be appropriate for moderate responders without distress. Discharge is reasonable when peak flow exceeds 70 percent of predicted, symptoms have clearly improved, lung examination demonstrates good air movement, and close follow-up within 48–72 hours is ensured.
Key Clinical Lessons And Safety Points
Altered mental status in an asthmatic patient signifies ventilatory failure until proven otherwise. Proper inhaler or nebulizer technique must be demonstrated prior to discharge, and peak flow monitoring should be encouraged. Routine intravenous fluids do not improve airway clearance in the absence of dehydration. Antibiotics are rarely indicated and should be reserved for clear evidence of bacterial infection such as pneumonia, fever with purulent sputum, or bacterial sinusitis.
- Published on
Emergency and Acute Medicine – Ascites
Clinical Overview
Ascites refers to the abnormal accumulation of serous fluid within the peritoneal cavity. The most common mechanism is portal hypertension, typically when portal pressures exceed 12 mm Hg, leading to intense renal sodium and water retention. Plasma volume expansion, impaired free-water excretion, and increased antidiuretic hormone release contribute to dilutional hyponatremia, which closely correlates with disease severity and prognosis. Reduced plasma oncotic pressure from hypoalbuminemia further promotes fluid extravasation, while peritoneal irritation from infection, inflammation, or malignancy may also play a role.
Underlying Causes
Parenchymal liver disease accounts for the majority of adult cases, most commonly cirrhosis and alcoholic hepatitis. Other hepatic causes include fulminant hepatic failure and hepatic venous outflow obstruction such as Budd–Chiari syndrome or veno-occlusive disease. Cardiac etiologies include congestive heart failure and constrictive pericarditis. Malignancy-related ascites may arise from peritoneal carcinomatosis or primary and metastatic liver tumors. Infectious causes include tuberculous, fungal, or bacterial peritonitis. Hypoalbuminemic states such as nephrotic syndrome and severe malnutrition may also produce ascites. Less common etiologies include pancreatic or biliary ascites, nephrogenic ascites, ovarian tumors, chylous ascites from lymphatic disruption, connective tissue disease, myxedema, and granulomatous peritonitis. In children, ascites most often results from malignancy, nephrotic syndrome, or malnutrition.
Clinical Features
Patients commonly present with progressive abdominal distention, discomfort, early satiety, weight gain, dyspnea, orthopnea, and peripheral edema. Rapid fluid accumulation is often poorly tolerated. Physical examination may reveal flank fullness, shifting dullness, fluid wave, abdominal hernias, muscle wasting, and signs of the underlying systemic disease. Flank dullness usually becomes evident when at least 500 mL of fluid is present, though detection may be difficult in obese patients.
Diagnostic Approach
Evaluation should focus on identifying liver disease, cardiac dysfunction, malignancy, infection, or systemic illness. Diagnostic paracentesis is essential in all cases of new-onset ascites and is mandatory in patients with fever, abdominal pain, worsening encephalopathy, or clinical deterioration. Ascitic fluid analysis should include cell count with differential, albumin, total protein, Gram stain, culture inoculated into blood culture bottles, glucose, LDH, and additional studies as indicated such as amylase, triglycerides, cytology, bilirubin, and tuberculosis testing.
Spontaneous bacterial peritonitis is defined by ascitic fluid polymorphonuclear leukocytes exceeding 250 cells/mm³ without a surgically correctable intra-abdominal source and often presents with subtle symptoms such as low-grade fever, abdominal discomfort, or altered mentation. Secondary bacterial peritonitis should be suspected when multiple organisms are seen on Gram stain and ascitic fluid demonstrates high protein, low glucose, and markedly elevated LDH.
Laboratory And Imaging Evaluation
Baseline studies include complete blood count, metabolic panel, liver function tests, coagulation profile, arterial blood gas or pulse oximetry, urinalysis, urine sodium, hepatitis serologies, amylase, lipase, alpha-fetoprotein, and thyroid studies when indicated. Ultrasound is useful to confirm ascites, assess abdominal organs, and guide paracentesis, particularly in low-volume cases. Doppler imaging evaluates hepatic blood flow, while CT scanning and chest radiography may identify malignancy, heart failure, or pulmonary complications.
The serum–ascites albumin gradient is a key diagnostic tool. A gradient of 1.1 g/dL or greater strongly suggests portal hypertension, whereas a lower gradient points toward malignancy, infection, pancreatic disease, or nephrotic syndrome.
Management Principles
Treatment depends on the underlying cause and aims to reduce ascitic volume while preserving effective intravascular circulation. Sudden abdominal pain, fever, or rapid distention warrants urgent reassessment for infection, hepatocellular carcinoma, hepatic outflow obstruction, or acute decompensation. Therapeutic paracentesis is indicated for tense ascites or respiratory compromise and can safely remove large volumes when hemodynamics are stable. Albumin replacement should be considered when more than 5 liters are removed.
Long-term control includes strict dietary sodium restriction and judicious use of diuretics. Spironolactone is preferred for cirrhotic ascites, often combined with furosemide in a fixed ratio. Weight loss targets should be conservative, and renal function and electrolytes must be closely monitored. Refractory ascites may require transjugular intrahepatic portosystemic shunting or liver transplantation. Nonsteroidal anti-inflammatory drugs should be avoided due to adverse renal effects and sodium retention.
Disposition And Follow-Up
Hospital admission is required for patients with spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, fulminant liver failure, or refractory tense ascites. Stable patients who respond to emergency management may be discharged with close follow-up. All new cases warrant gastroenterology evaluation, while established cases should continue coordinated outpatient care.
Clinical Insights And Common Pitfalls
New-onset ascites always requires a complete diagnostic evaluation and specialist involvement. Symptoms of spontaneous bacterial peritonitis are frequently subtle, demanding a low threshold for paracentesis. Coagulopathy alone is not a contraindication to paracentesis, as diagnostic benefit outweighs bleeding risk. Ultrasound guidance improves safety and success, particularly in patients with small-volume ascites.
Clinical Overview
Ascites refers to the abnormal accumulation of serous fluid within the peritoneal cavity. The most common mechanism is portal hypertension, typically when portal pressures exceed 12 mm Hg, leading to intense renal sodium and water retention. Plasma volume expansion, impaired free-water excretion, and increased antidiuretic hormone release contribute to dilutional hyponatremia, which closely correlates with disease severity and prognosis. Reduced plasma oncotic pressure from hypoalbuminemia further promotes fluid extravasation, while peritoneal irritation from infection, inflammation, or malignancy may also play a role.
Underlying Causes
Parenchymal liver disease accounts for the majority of adult cases, most commonly cirrhosis and alcoholic hepatitis. Other hepatic causes include fulminant hepatic failure and hepatic venous outflow obstruction such as Budd–Chiari syndrome or veno-occlusive disease. Cardiac etiologies include congestive heart failure and constrictive pericarditis. Malignancy-related ascites may arise from peritoneal carcinomatosis or primary and metastatic liver tumors. Infectious causes include tuberculous, fungal, or bacterial peritonitis. Hypoalbuminemic states such as nephrotic syndrome and severe malnutrition may also produce ascites. Less common etiologies include pancreatic or biliary ascites, nephrogenic ascites, ovarian tumors, chylous ascites from lymphatic disruption, connective tissue disease, myxedema, and granulomatous peritonitis. In children, ascites most often results from malignancy, nephrotic syndrome, or malnutrition.
Clinical Features
Patients commonly present with progressive abdominal distention, discomfort, early satiety, weight gain, dyspnea, orthopnea, and peripheral edema. Rapid fluid accumulation is often poorly tolerated. Physical examination may reveal flank fullness, shifting dullness, fluid wave, abdominal hernias, muscle wasting, and signs of the underlying systemic disease. Flank dullness usually becomes evident when at least 500 mL of fluid is present, though detection may be difficult in obese patients.
Diagnostic Approach
Evaluation should focus on identifying liver disease, cardiac dysfunction, malignancy, infection, or systemic illness. Diagnostic paracentesis is essential in all cases of new-onset ascites and is mandatory in patients with fever, abdominal pain, worsening encephalopathy, or clinical deterioration. Ascitic fluid analysis should include cell count with differential, albumin, total protein, Gram stain, culture inoculated into blood culture bottles, glucose, LDH, and additional studies as indicated such as amylase, triglycerides, cytology, bilirubin, and tuberculosis testing.
Spontaneous bacterial peritonitis is defined by ascitic fluid polymorphonuclear leukocytes exceeding 250 cells/mm³ without a surgically correctable intra-abdominal source and often presents with subtle symptoms such as low-grade fever, abdominal discomfort, or altered mentation. Secondary bacterial peritonitis should be suspected when multiple organisms are seen on Gram stain and ascitic fluid demonstrates high protein, low glucose, and markedly elevated LDH.
Laboratory And Imaging Evaluation
Baseline studies include complete blood count, metabolic panel, liver function tests, coagulation profile, arterial blood gas or pulse oximetry, urinalysis, urine sodium, hepatitis serologies, amylase, lipase, alpha-fetoprotein, and thyroid studies when indicated. Ultrasound is useful to confirm ascites, assess abdominal organs, and guide paracentesis, particularly in low-volume cases. Doppler imaging evaluates hepatic blood flow, while CT scanning and chest radiography may identify malignancy, heart failure, or pulmonary complications.
The serum–ascites albumin gradient is a key diagnostic tool. A gradient of 1.1 g/dL or greater strongly suggests portal hypertension, whereas a lower gradient points toward malignancy, infection, pancreatic disease, or nephrotic syndrome.
Management Principles
Treatment depends on the underlying cause and aims to reduce ascitic volume while preserving effective intravascular circulation. Sudden abdominal pain, fever, or rapid distention warrants urgent reassessment for infection, hepatocellular carcinoma, hepatic outflow obstruction, or acute decompensation. Therapeutic paracentesis is indicated for tense ascites or respiratory compromise and can safely remove large volumes when hemodynamics are stable. Albumin replacement should be considered when more than 5 liters are removed.
Long-term control includes strict dietary sodium restriction and judicious use of diuretics. Spironolactone is preferred for cirrhotic ascites, often combined with furosemide in a fixed ratio. Weight loss targets should be conservative, and renal function and electrolytes must be closely monitored. Refractory ascites may require transjugular intrahepatic portosystemic shunting or liver transplantation. Nonsteroidal anti-inflammatory drugs should be avoided due to adverse renal effects and sodium retention.
Disposition And Follow-Up
Hospital admission is required for patients with spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, fulminant liver failure, or refractory tense ascites. Stable patients who respond to emergency management may be discharged with close follow-up. All new cases warrant gastroenterology evaluation, while established cases should continue coordinated outpatient care.
Clinical Insights And Common Pitfalls
New-onset ascites always requires a complete diagnostic evaluation and specialist involvement. Symptoms of spontaneous bacterial peritonitis are frequently subtle, demanding a low threshold for paracentesis. Coagulopathy alone is not a contraindication to paracentesis, as diagnostic benefit outweighs bleeding risk. Ultrasound guidance improves safety and success, particularly in patients with small-volume ascites.
- Published on
Emergency and Acute Medicine – Bartholin Abscess
Overview And Definitions
The Bartholin glands are paired structures located inferiorly on each side of the vaginal introitus, with ducts opening into the labial vestibule. Obstruction of a duct results in a typically painless cyst, whereas secondary infection of the cyst leads to abscess formation.
Epidemiology
Bartholin abscesses occur most commonly in women between 20 and 40 years of age.
Etiology
Infection is usually polymicrobial and reflects normal vaginal flora, including anaerobic and aerobic organisms such as Bacteroides species, Peptostreptococcus species, Escherichia coli, and other gram-negative bacteria. Sexually transmitted pathogens such as Neisseria gonorrhoeae and Chlamydia trachomatis are less common but should be considered.
Clinical Presentation
Patients typically present with acute-onset, unilateral labial swelling that is painful and progressive. Pain is often exacerbated by sitting, walking, or sexual intercourse. Examination reveals a tender, fluctuant mass along the posterolateral aspect of the vaginal vestibule, frequently accompanied by warmth and erythema. Fever is uncommon. In contrast, a Bartholin cyst presents as a painless, unilateral labial mass.
Evaluation
Diagnosis is clinical and based on identification of a localized, tender, fluctuant mass in the region of the Bartholin gland. Routine imaging is not required. Abscess material and cervical samples should be cultured for gonorrhea and chlamydia when sexually transmitted infection is a concern.
Differential Diagnosis
Consider Bartholin cyst, carcinoma of the Bartholin gland (rare, especially important in women over 40 years), and perineal hernia.
Emergency Department Management
Definitive treatment is prompt incision and drainage under local anesthesia with the patient in the lithotomy position. Adequate analgesia, including narcotics if needed, improves patient comfort.
Simple incision and drainage involves making a stab incision on the mucosal surface of the abscess, parallel to the hymenal ring, penetrating both the labial mucosa and abscess wall to allow free drainage. The cavity is packed with gauze, with packing removal planned in 24–48 hours, and sitz baths initiated after 24 hours.
The Word catheter technique uses a small balloon-tipped catheter placed through a small incision into the abscess cavity, inflated with 2–4 mL of water, and left in place for 6–8 weeks to allow epithelialization and reduce recurrence. Sitz baths may begin after 24 hours, with short-term follow-up to ensure proper positioning.
Marsupialization creates a permanent drainage tract by suturing the abscess cavity to the labial mucosa. This method is technically more complex and generally reserved for gynecologic specialists.
Antibiotic Therapy
Antibiotics are not routinely required after adequate drainage. They may be indicated for surrounding cellulitis, immunocompromised patients, or suspected sexually transmitted infection. Broad-spectrum oral regimens may include amoxicillin–clavulanate or ciprofloxacin combined with metronidazole.
Disposition And Follow-Up
Admission is indicated for patients with sepsis, extensive cellulitis, or concern for necrotizing infection. Most patients can be discharged with clear follow-up plans. Gynecologic follow-up is recommended within 24–48 hours after packing removal or 2–4 days after Word catheter placement. Sitz baths should be continued for at least 72 hours.
Clinical Insights And Common Errors
A painless Bartholin cyst does not require emergent intervention and should not be confused with an abscess. Malignancy should be considered in women over 40 presenting with a new Bartholin mass. Incisions should always be made on the mucosal surface to minimize scarring and recurrence.
Overview And Definitions
The Bartholin glands are paired structures located inferiorly on each side of the vaginal introitus, with ducts opening into the labial vestibule. Obstruction of a duct results in a typically painless cyst, whereas secondary infection of the cyst leads to abscess formation.
Epidemiology
Bartholin abscesses occur most commonly in women between 20 and 40 years of age.
Etiology
Infection is usually polymicrobial and reflects normal vaginal flora, including anaerobic and aerobic organisms such as Bacteroides species, Peptostreptococcus species, Escherichia coli, and other gram-negative bacteria. Sexually transmitted pathogens such as Neisseria gonorrhoeae and Chlamydia trachomatis are less common but should be considered.
Clinical Presentation
Patients typically present with acute-onset, unilateral labial swelling that is painful and progressive. Pain is often exacerbated by sitting, walking, or sexual intercourse. Examination reveals a tender, fluctuant mass along the posterolateral aspect of the vaginal vestibule, frequently accompanied by warmth and erythema. Fever is uncommon. In contrast, a Bartholin cyst presents as a painless, unilateral labial mass.
Evaluation
Diagnosis is clinical and based on identification of a localized, tender, fluctuant mass in the region of the Bartholin gland. Routine imaging is not required. Abscess material and cervical samples should be cultured for gonorrhea and chlamydia when sexually transmitted infection is a concern.
Differential Diagnosis
Consider Bartholin cyst, carcinoma of the Bartholin gland (rare, especially important in women over 40 years), and perineal hernia.
Emergency Department Management
Definitive treatment is prompt incision and drainage under local anesthesia with the patient in the lithotomy position. Adequate analgesia, including narcotics if needed, improves patient comfort.
Simple incision and drainage involves making a stab incision on the mucosal surface of the abscess, parallel to the hymenal ring, penetrating both the labial mucosa and abscess wall to allow free drainage. The cavity is packed with gauze, with packing removal planned in 24–48 hours, and sitz baths initiated after 24 hours.
The Word catheter technique uses a small balloon-tipped catheter placed through a small incision into the abscess cavity, inflated with 2–4 mL of water, and left in place for 6–8 weeks to allow epithelialization and reduce recurrence. Sitz baths may begin after 24 hours, with short-term follow-up to ensure proper positioning.
Marsupialization creates a permanent drainage tract by suturing the abscess cavity to the labial mucosa. This method is technically more complex and generally reserved for gynecologic specialists.
Antibiotic Therapy
Antibiotics are not routinely required after adequate drainage. They may be indicated for surrounding cellulitis, immunocompromised patients, or suspected sexually transmitted infection. Broad-spectrum oral regimens may include amoxicillin–clavulanate or ciprofloxacin combined with metronidazole.
Disposition And Follow-Up
Admission is indicated for patients with sepsis, extensive cellulitis, or concern for necrotizing infection. Most patients can be discharged with clear follow-up plans. Gynecologic follow-up is recommended within 24–48 hours after packing removal or 2–4 days after Word catheter placement. Sitz baths should be continued for at least 72 hours.
Clinical Insights And Common Errors
A painless Bartholin cyst does not require emergent intervention and should not be confused with an abscess. Malignancy should be considered in women over 40 presenting with a new Bartholin mass. Incisions should always be made on the mucosal surface to minimize scarring and recurrence.
- Published on
Emergency and Acute Medicine – Barbiturates Poisoning
Overview and Definitions
Barbiturates are sedative–hypnotic agents derived from barbituric acid that exert their effects by enhancing γ-aminobutyric acid (GABA) activity at the GABA-A receptor. At toxic concentrations, they directly open chloride channels, leading to profound CNS depression. Additional effects include inhibition of vascular smooth muscle tone and direct myocardial depression, which contribute to hypotension and shock. Poisoning may be intentional or accidental.
Etiology
Toxicity results from overdose of barbiturates, either intentional (suicide attempt) or unintentional due to medication error, drug interactions, or dose escalation.
Clinical Features
Central nervous system findings range from lethargy, slurred speech, incoordination, ataxia, and loss of reflexes to deep coma that can closely resemble brain death. Cardiovascular manifestations include hypotension and bradycardia. Respiratory depression and hypothermia are common. Ophthalmologic findings may include miosis, nystagmus, and dysconjugate gaze. Characteristic bullae, known as “barb blisters,” may develop, particularly after prolonged immobilization.
History and Examination
Assessment should focus on determining intent, including evidence of pill bottles, history of depression or suicidal ideation, and recent medication changes. Estimating the duration of unresponsiveness is important. Examination typically reveals CNS depression ranging from ataxia to coma, respiratory compromise, hypotension, bradycardia, hypothermia, abnormal eye movements, and skin bullae.
Essential Evaluation
Immediate assessment includes fingerstick glucose, continuous oxygen saturation monitoring, and blood pressure measurement. A critical caution is that barbiturate poisoning can mimic brain death; this diagnosis must not be made until drug effects are excluded.
Diagnostic Testing
Laboratory studies include electrolytes, BUN, creatinine, glucose, and anion gap assessment, along with urinalysis for myoglobin and crystalluria, creatine phosphokinase for rhabdomyolysis, and urine toxicology screening. Serum phenobarbital levels should be obtained when suspected, with acetaminophen and salicylate levels assessed in possible suicide attempts. Imaging may include noncontrast head CT for altered mental status and chest radiography if aspiration is suspected. Lumbar puncture is reserved for selected cases where CNS infection is a concern.
Differential Diagnosis
Consider other sedative–hypnotic intoxications including GHB, carbon monoxide poisoning, CNS infections, intracranial mass lesions, hypoglycemia, uremia, electrolyte disturbances such as hypermagnesemia, postictal states, hypothyroidism, hepatic failure, and primary psychiatric conditions.
Prehospital Care
Moderate to severe poisonings require paramedic transport. Airway protection with intubation is often necessary due to respiratory depression or loss of protective reflexes. Supplemental oxygen, IV access, and fluid boluses for hypotension should be initiated promptly.
Initial Stabilization and Emergency Management
Management priorities follow ABC principles. Severe toxicity frequently necessitates endotracheal intubation and mechanical ventilation. Hypotension should be treated with aggressive isotonic fluid resuscitation, typically 1–2 liters of normal saline, with vasopressors added if shock persists. Activated charcoal effectively binds barbiturates and reduces absorption.
Therapeutic Interventions
A single dose of activated charcoal is most effective if administered within one hour of ingestion, provided the airway is protected. Repeated-dose activated charcoal may be used as “gut dialysis” every 2–4 hours if bowel sounds are present. Hypothermia should be corrected with active rewarming. Refractory hypotension requires vasopressor support. Hyperkalemia from rhabdomyolysis should be treated with standard therapies. Phenobarbital levels should be rechecked within 2–4 hours to assess trends. Hemodialysis is indicated in cases of renal failure, prolonged coma, phenobarbital levels above 100 mg/dL, or refractory hypotension. Urinary alkalinization has no role.
Medications
Activated charcoal is given at 1 g/kg orally. Dopamine may be initiated at 5–10 μg/kg/min and titrated as needed, with norepinephrine as an alternative at 2–4 μg/min. Epinephrine may be used as second-line vasopressor therapy.
Disposition and Follow-Up
ICU admission is required for patients with coma, respiratory depression, hypotension, hypothermia, or rhabdomyolysis. Discharge may be considered after at least six hours of observation in asymptomatic patients with two consecutive subtoxic phenobarbital levels. Intentional overdoses mandate psychiatric evaluation, while unintentional cases require medication review and adjustment.
Key Clinical Insights and Common Errors
Profound hypothermia is common and requires accurate core temperature measurement. Rhabdomyolysis should be actively sought, especially in patients with prolonged immobilization. Barbiturate toxicity can cause extended coma, and clinicians must ensure complete drug clearance before considering a diagnosis of brain death.
Overview and Definitions
Barbiturates are sedative–hypnotic agents derived from barbituric acid that exert their effects by enhancing γ-aminobutyric acid (GABA) activity at the GABA-A receptor. At toxic concentrations, they directly open chloride channels, leading to profound CNS depression. Additional effects include inhibition of vascular smooth muscle tone and direct myocardial depression, which contribute to hypotension and shock. Poisoning may be intentional or accidental.
Etiology
Toxicity results from overdose of barbiturates, either intentional (suicide attempt) or unintentional due to medication error, drug interactions, or dose escalation.
Clinical Features
Central nervous system findings range from lethargy, slurred speech, incoordination, ataxia, and loss of reflexes to deep coma that can closely resemble brain death. Cardiovascular manifestations include hypotension and bradycardia. Respiratory depression and hypothermia are common. Ophthalmologic findings may include miosis, nystagmus, and dysconjugate gaze. Characteristic bullae, known as “barb blisters,” may develop, particularly after prolonged immobilization.
History and Examination
Assessment should focus on determining intent, including evidence of pill bottles, history of depression or suicidal ideation, and recent medication changes. Estimating the duration of unresponsiveness is important. Examination typically reveals CNS depression ranging from ataxia to coma, respiratory compromise, hypotension, bradycardia, hypothermia, abnormal eye movements, and skin bullae.
Essential Evaluation
Immediate assessment includes fingerstick glucose, continuous oxygen saturation monitoring, and blood pressure measurement. A critical caution is that barbiturate poisoning can mimic brain death; this diagnosis must not be made until drug effects are excluded.
Diagnostic Testing
Laboratory studies include electrolytes, BUN, creatinine, glucose, and anion gap assessment, along with urinalysis for myoglobin and crystalluria, creatine phosphokinase for rhabdomyolysis, and urine toxicology screening. Serum phenobarbital levels should be obtained when suspected, with acetaminophen and salicylate levels assessed in possible suicide attempts. Imaging may include noncontrast head CT for altered mental status and chest radiography if aspiration is suspected. Lumbar puncture is reserved for selected cases where CNS infection is a concern.
Differential Diagnosis
Consider other sedative–hypnotic intoxications including GHB, carbon monoxide poisoning, CNS infections, intracranial mass lesions, hypoglycemia, uremia, electrolyte disturbances such as hypermagnesemia, postictal states, hypothyroidism, hepatic failure, and primary psychiatric conditions.
Prehospital Care
Moderate to severe poisonings require paramedic transport. Airway protection with intubation is often necessary due to respiratory depression or loss of protective reflexes. Supplemental oxygen, IV access, and fluid boluses for hypotension should be initiated promptly.
Initial Stabilization and Emergency Management
Management priorities follow ABC principles. Severe toxicity frequently necessitates endotracheal intubation and mechanical ventilation. Hypotension should be treated with aggressive isotonic fluid resuscitation, typically 1–2 liters of normal saline, with vasopressors added if shock persists. Activated charcoal effectively binds barbiturates and reduces absorption.
Therapeutic Interventions
A single dose of activated charcoal is most effective if administered within one hour of ingestion, provided the airway is protected. Repeated-dose activated charcoal may be used as “gut dialysis” every 2–4 hours if bowel sounds are present. Hypothermia should be corrected with active rewarming. Refractory hypotension requires vasopressor support. Hyperkalemia from rhabdomyolysis should be treated with standard therapies. Phenobarbital levels should be rechecked within 2–4 hours to assess trends. Hemodialysis is indicated in cases of renal failure, prolonged coma, phenobarbital levels above 100 mg/dL, or refractory hypotension. Urinary alkalinization has no role.
Medications
Activated charcoal is given at 1 g/kg orally. Dopamine may be initiated at 5–10 μg/kg/min and titrated as needed, with norepinephrine as an alternative at 2–4 μg/min. Epinephrine may be used as second-line vasopressor therapy.
Disposition and Follow-Up
ICU admission is required for patients with coma, respiratory depression, hypotension, hypothermia, or rhabdomyolysis. Discharge may be considered after at least six hours of observation in asymptomatic patients with two consecutive subtoxic phenobarbital levels. Intentional overdoses mandate psychiatric evaluation, while unintentional cases require medication review and adjustment.
Key Clinical Insights and Common Errors
Profound hypothermia is common and requires accurate core temperature measurement. Rhabdomyolysis should be actively sought, especially in patients with prolonged immobilization. Barbiturate toxicity can cause extended coma, and clinicians must ensure complete drug clearance before considering a diagnosis of brain death.
